• Issue

    European Journal of Heart Failure Supplements: Volume 6, Issue S1

    i, 1-228
    June 2007
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Abstracts

Free Access

8 Which is the best time to perform ICD implantation in patients with idiopathic dilated cardiomyopathy?

M. Zecchin,  A. Di Lenarda,  A. Pivetta,  M. Merlo,  D. Gregori,  F. Brun,  C. Chicco,  G. Sinagra,  on behalf of The Trieste Heart Muscle Disease Registry , 
  • Page: i
  • First Published: 11 December 2008
Free Access

40 MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure

T. Thum,  P. Galuppo,  S. Kneitz,  C. Wolf,  L. Van Laake,  S. Engelhardt,  G. Ertl,  J. Bauersachs, 
  • Page: 1
  • First Published: 11 December 2008
Free Access

41 Adaptive servoventilation improves sleep-disordered breathing and cardiopulmonary function in patients with chronic heart failure and Cheyne-Stokes respiration

O. Oldenburg,  B. Lamp,  A. Schmidt,  A. Teigeler,  D. Horstkotte, 
  • Page: 1
  • First Published: 11 December 2008
Free Access

42 Clinical and prognostic role of flow-mediated vasodilatory response in stable chronic heart failure

L.G. Voronkov,  I.A. Shkurat,  E.M. Besaga, 
  • Pages: 1-2
  • First Published: 11 December 2008
Free Access

10 Clinical utility of an implantable thoracic impedance monitoring and alert system: beyond hospitalization

F. Oliva,  M. Landolina,  G. Vergara,  G. Lonardi,  G.B. Perego,  P. Diotallevi,  A. Denaro,  A. Varbaro, 
  • Page: 2
  • First Published: 11 December 2008
Free Access

11 Cause-of-death analysis in moderate heart failure patients with an implantable cardioverter defibrillator. Results of a multicentric French cohort study

E. Marijon,  L. Trinquart,  F. Anselme,  D. Babuty,  G. Chatellier,  J.Y. Le Heuzey, 
  • Page: 2
  • First Published: 11 December 2008
Free Access

12 Alterations of pulmonary artery pressure in patients with a new axial flow left ventricular device

G. Moukarbel,  S. Ennis,  S. Moore,  T. Macgillivray, 
  • Page: 2
  • First Published: 11 December 2008
Free Access

43 Prognosis value of fibrosis with gadolinium-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy in non-selected patients

A. Valle,  M. Nadal,  J. Estornell,  M. Corbi,  M. Gimenez,  R. Romaguera,  A. Laynez,  F. Ridocci, 
  • Page: 4
  • First Published: 11 December 2008
Free Access

44 Beneficial effects of pharmacological enhancement of the endothelial NO synthases on cardiac function and hypertrophy in an animal model of heart failure despite normal EF

D. Westermann,  S. Jaeger,  A. Riad,  U. Richter,  H.P. Schultheiss,  M. Pauschinger,  C. Tschöpe, 
  • Page: 4
  • First Published: 11 December 2008
Free Access

45 Suppression of class I histone deacetylase blunts cardiac hypertrophy: in vitro and in vivo evidence

P. Gallo,  S. Grimaldi,  P. Gallo,  R. De Francesco,  P. Gallinari,  P. Jones,  C. Steinkuhler,  G. Condorelli, 
  • Pages: 4-5
  • First Published: 11 December 2008
Free Access

47 Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility

N. Burkard,  A.G. Rokita,  S.G. Kaufmann,  M. Hallhuber,  C. Gebhardt,  K. Hu,  L.S. Maier,  O. Ritter, 
  • Page: 6
  • First Published: 11 December 2008
Free Access

48 Eplerenone treatment in a CVB-3 induced myocarditis model reduces cardiac fibrosis resulting in an improved left ventricular function

S. Jaeger,  A. Riad,  R. Arndt,  S. Rutschow,  K. Puhl,  H.P. Schultheiss,  C. Tschöpe,  M. Pauschinger, 
  • Page: 6
  • First Published: 11 December 2008
Free Access

49 Toll-like receptor 4 deficiency reduces LV remodelling and mortality rate after myocardial infarction in mice

A. Riad,  S. Jaeger,  S. Sobirey,  A. Yaulema-Riss,  S. Bereswill,  H.P. Schultheiss,  M. Pauschinger,  C. Tschöpe, 
  • Page: 7
  • First Published: 11 December 2008
Free Access

50 NF-kappaB regulates adaptive cardiac hypertrophy

C. Gehrke,  A. Renger,  R. Van Der Nagel,  L. Zelarayan,  C. Scheidereit,  L. De Windt,  M.W. Bergmann, 
  • Page: 7
  • First Published: 11 December 2008
Free Access

51 Maladaptive remodelling post myocardial infarction in calsarcin-1 deficient mice

D. Frank,  K. Kruschandl,  B. Helmke,  H.A. Katus,  N. Frey, 
  • Pages: 7-8
  • First Published: 11 December 2008
Free Access

52 Sex-differences in early left ventricular genomic response to pressure overload in mice

S. Brokat,  H. Witt,  J. Jaekel,  C.H. Grohe,  S.T. Roepcke,  P. Ruiz Noppinger,  V. Regitz-Zagrosek, 
  • Page: 8
  • First Published: 11 December 2008
Free Access

53 Cardiac contractility modulation electrical signals improve LV diastolic function in dogs with heart failure

H.N. Sabbah,  V. Zaca,  M. Wang,  A. Jiang,  S. Rastogi,  B. Rousso,  Y. Mika, 
  • Page: 8
  • First Published: 11 December 2008
Free Access

54 Prohibition of calcineurin/importin-interaction disrupts calcineurin/NFAT cascade

M. Hallhuber,  N. Burkard,  C. Gebhardt,  O. Ritter, 
  • Page: 8
  • First Published: 11 December 2008
Free Access

55 Time dependent increase in myocardial distensibility after an acute preload elevation

J. Martins,  A.L. Pires,  R. Ladeiras-Lopes,  D. Monteiro-Sousa,  C. Bras-Silva,  A. Leite-Moreira, 
  • Page: 9
  • First Published: 11 December 2008
Free Access

57 A multivariate model to predict further one-year cardiac mortality applied at discharge from heart failure hospitalization. Value of paired samples of NT-proBNP in community hospitals

M. Bonastre Thio,  M. Lopez Rodriguez,  G. Vidal Cusido,  E. Berlanga Escalera,  E. Guilera Mas,  R. Sanchez Lomares,  J. Font Rocabayera,  A. Martinez Rubio, 
  • Page: 9
  • First Published: 11 December 2008
Free Access

58 Natriuretic peptides for monitoring therapy in heart failure patients need to be evaluated using reference change value

L. Zanolla,  L. Tomasi,  G. Zanotto,  C. Cocco,  M.S. Graziani,  C. Lo Cascio,  P. Rizzotti,  C. Vassanelli, 
  • Pages: 9-10
  • First Published: 11 December 2008
Free Access

59 BNP predicts echocardiographic severity of diastolic dysfunction in heart failure

J. Grewal,  E. Lonn,  H. Persson,  P. Tait,  J. Carlson,  R. McKelvie, 
  • Page: 10
  • First Published: 11 December 2008
Free Access

60 Mid-regional pro-atrial natriuretic peptide (MR-proANP) predicts risk of death or heart failure in patients with acute myocardial infarction

S.Q. Khan,  O. Dhillon,  R.J. O'Brien,  J. Struck,  N.G. Morgenthaler,  I. Squire,  A. Bergmann,  L.L. Ng, 
  • Page: 10
  • First Published: 11 December 2008
Free Access

61 The relationship between N-terminal B-type natriuretic peptide and circulating markers of extracellular cardiac remodelling in patients following complicated myocardial infarction

C. Manhenke,  S. Orn,  I. Squire,  F. Zannad,  K. Dickstein, 
  • Pages: 10-11
  • First Published: 11 December 2008
Free Access

62 Prognostic role of NT-proXNP, a novel virtual analyte, in acute heart failure

K. Miettinen,  J. Magga,  O. Vuolteenaho,  J. Lassus,  V.P. Harjola,  K. Siirila-Waris,  M.S. Nieminen,  K.J. Peuhkurinen,  on behalf of FINN-AKVA study group , 
  • Page: 11
  • First Published: 11 December 2008
Free Access

63 Sudden death prediction of NT-proBNP in chronic heart failure: a word of caution

A. De Bernardi,  G.M. Miotto,  F. Balagna, 
  • Page: 11
  • First Published: 11 December 2008
Free Access

64 The role of NT-proBNP for detecting asymptomatic left ventricular dysfunction in subjects at risk of heart failure. Results of the PROBE-HF study

G. Castelli,  I. Betti,  A. Barchielli,  V. Boscherini,  B. Cappelli,  G. Messeri,  M. Gheorghiade,  A. Zuppiroli, 
  • Page: 12
  • First Published: 11 December 2008
Free Access

65 Design, synthesis and unique biological actions of CD-NP: a novel CNP-like chimeric natriuretic peptide

O. Lisy,  B.K. Huntley,  D.J. McCormick,  J.C. Burnett, 
  • Page: 12
  • First Published: 11 December 2008
Free Access

66 Serial NT-BNP in heart failure: the influence of changing haemoglobin, renal function and body weight over time

A. Murphy,  S. Polymeros,  S. Melcher,  R.A.P. Weir,  H.J. Dargie, 
  • Page: 12
  • First Published: 11 December 2008
Free Access

67 Pulmonary artery systolic pressure is an independent predictor of N-terminal pro-B-type natriuretic peptide in systolic heart failure

J. Silva Marques,  C. David,  A.G. Almeida,  M.G. Lopes, 
  • Page: 13
  • First Published: 11 December 2008
Free Access

68 Extent of myocardial scar: Does it affect improvement of neurohormonal activation after levosimendan infusion?

A.N. Kitsiou,  P. Kelepouris,  A. Anadiotis,  S. Karas, 
  • Page: 13
  • First Published: 11 December 2008
Free Access

69 Utility of NT-proBNP as a screening tool for ventricular dysfunction and hypertrophy in patients with long standing Diabetes Mellitus

P. Reddy,  L.L. Tin,  P.H. Loh,  G. Mathur,  A.S. Rigby,  K.M. Goode,  A.L. Clark,  J.G.F. Cleland,  on behalf of Academic Cardiology, University of Hull , 
  • Page: 13
  • First Published: 11 December 2008
Free Access

70 Diagnostic value of serum B-type natriuretic peptide in the diagnosis of congestive heart failure in patients with impaired renal function - do we need a higher cutoff?

D. Karia,  J. Mendoza,  R. Ishac,  H. Ra,  P. Fumo, 
  • Page: 14
  • First Published: 11 December 2008
Free Access

71 Improved early diagnosis of heart failure with B-type natriuretic peptides: comparison between BNP and NT-proBNP diagnostic accuracy

M. Fontana,  L. Zyw,  R. Poletti,  C. Prontera,  C. Passino,  A. Gabutti,  A. Giannoni,  M. Emdin, 
  • Page: 14
  • First Published: 11 December 2008
Free Access

73 Impact of renal function on the prognosis of chronic heart failure

M. Dekany,  B. Szabo,  N. Nyolczas,  T. Borsanyi,  J. Bencze,  E. Marosi,  I. Preda,  R.G. Kiss, 
  • Page: 14
  • First Published: 11 December 2008
Free Access

74 Testosterone predicts low functional capacity and morbility in male patients with chronic heart failure

G. Caminiti,  M. Volterrani,  R. Massaro,  G. Marazzi,  C. Vitale,  M. Miceli,  G. Rosano, 
  • Page: 15
  • First Published: 11 December 2008
Free Access

75 Oscillatory ventilation at rest coexisting with increased ventilatory response to exercise allow to identify heart failure patients with very poor outcome

T. Witkowski,  K. Nowak,  A. Grzeslo,  E.A. Jankowska,  J. Petruk-Kowalczyk,  W. Banasiak,  P. Ponikowski, 
  • Page: 15
  • First Published: 11 December 2008
Free Access

76 The effect of improvement of left ventricular ejection fraction and reverse remodelling on survival in chronic heart failure

N. Nyolczas,  M. Dekany,  B. Szabo,  T. Borsanyi,  J. Bencze,  E. Marosi,  I. Preda,  R. Kiss, 
  • Pages: 15-16
  • First Published: 11 December 2008
Free Access

77 C-type natriuretic peptide regulation in Chagas disease and other dilated cardiomyopathies

M.C.V. Moreira,  S. Heringer-Walther,  N. Wessel,  T.M. Ventura,  I. Araujo,  H.P. Schultheiss,  T. Walther, 
  • Page: 16
  • First Published: 11 December 2008
Free Access

78 Relation of loop diuretic dose to mortality in advanced heart failure and left ventricular systolic dysfunction

B. Redondo,  J.A. Hurtado,  D.A. Pascual Figal,  P. Penafiel,  I.P. Garrido,  F. Pastor,  J.A. Giner,  M. Valdes, 
  • Page: 16
  • First Published: 11 December 2008
Free Access

79 Serum tumor necrosis-alpha levels upon discharge predict 180-day mortality in patients hospitalized for acute decompensated chronic heart failure

D. Mytas,  M. Zairis,  K. Kontos,  M. Prodromiti,  P. Batika-Zairi,  S. Makrygiannis,  E. Gougourela,  S. Foussas, 
  • Pages: 16-17
  • First Published: 11 December 2008
Free Access

80 Cost effectiveness of B-type natriuretic peptide and echocardiography for predicting major outcome in suspected heart failure patients referred from the community

T.K. Lim,  E. Celik,  D. Gaze,  P.O. Collinson,  R. Senior, 
  • Page: 17
  • First Published: 11 December 2008
Free Access

81 Does body mass index influence mortality in patients with chronic heart failure?

E. Zamora,  J. Lupon,  A. Urrutia,  B. Gonzalez,  D. Mas,  M. Domingo,  C. Diez,  V. Valle, 
  • Page: 17
  • First Published: 11 December 2008
Free Access

82 Worsening renal function and prognosis in heart failure; a meta-analysis of published studies

K. Damman,  G. Navis,  A.A. Voors,  D.J. Van Veldhuisen,  H.L. Hillege, 
  • Pages: 17-18
  • First Published: 11 December 2008
Free Access

83 Prognostic additional value of cardiopulmonary exercise test in risk assessment of elderly patients with chronic heart failure

A.B. Scardovi,  R. De Maria,  C. Coletta,  N. Aspromonte,  S. Perna,  R. Ricci,  V. Ceci,  on behalf of M. Feola, G.L. Rosso, P. D'Errigo, A. Pimpinella , 
  • Page: 18
  • First Published: 11 December 2008
Free Access

84 Rest-redistribution 201Tl SPECT predicts myocardial infarction and cardiac death in patients with ischemic left ventricular dysfunction

L. Corrado,  M. Cafiero,  A. Marzano,  S. Paolillo,  P. Cesarano,  P. Gargiulo,  P. Costanzo,  P. Perrone Filardi, 
  • Page: 18
  • First Published: 11 December 2008
Free Access

85 The value of repeated measurement of N-terminal pro-B-type natriuretic peptide for prognostic stratification in chronic heart failure

M. Kubanek,  K. Goode,  A. Rab Shaikh,  I. Hanning,  A.L. Clark,  J.G.F. Cleland, 
  • Pages: 18-19
  • First Published: 11 December 2008
Free Access

86 Relevance of serial measurements of N-terminal-pro-brain natriuretic peptide in an outpatients ward for heart failure

R. Jarai,  D. Cilesiz,  J. Cup,  C. Primus,  I. Kozanli,  G. Jakl,  K. Huber, 
  • Page: 19
  • First Published: 11 December 2008
Free Access

87 Beta blockers improve long-term survival in patients with end-stage heart failure and depression, only when combined with selective serotonin reuptake inhibitors

D. Tousoulis,  A. Drolias,  C. Antoniades,  C. Tentolouris,  S. Brilli,  A. Trikas,  E. Vavuranakis,  C. Stefanadis, 
  • Page: 19
  • First Published: 11 December 2008
Free Access

88 Long-term prognostic value of peak VO2 in patients with heart failure on chronic beta-blocker therapy

M. Metra,  S. Nodari,  T. Bordonali,  C. Lombardi,  A. Saporetti,  F. Fracassi,  R. Danesi,  L. Dei Cas, 
  • Pages: 19-20
  • First Published: 11 December 2008
Free Access

89 Clinical course in patients with active myocarditis according to the type of clinical presentation

G. Sinagra,  M. Merlo,  A. Magagnin,  F. Silvestri,  M. Giacca,  G. Sabbadini,  L. Massa,  A. DiLenarda,  on behalf of Trieste Heart Muscle Disease Registry , 
  • Page: 20
  • First Published: 11 December 2008
Free Access

90 Is the paradoxical relationship between body mass index and mortality in patients with heart failure influenced by left ventricle ejection fraction?

E. Zamora,  J. Lupon,  A. Urrutia,  B. Gonzalez,  D. Mas,  M. Domingo,  T. Pascual,  V. Valle, 
  • Page: 20
  • First Published: 11 December 2008
Free Access

91 Interpretation of repeated measurements of amino-terminal B-type natriuretic peptide in ambulatory heart failure patients after discharge depends on individual patient risk

D. Moertl,  A. Hammer,  M. Huelsmann,  R. Pacher,  R. Berger, 
  • Pages: 20-21
  • First Published: 11 December 2008
Free Access

92 Low BMI as an independent risk factor of death in patients with severe heart failure subjected to aortic valve replacement

M. Banach,  A. Goch,  P. Okonski,  M. Barylski,  J. Rysz,  R. Jaszewski,  J.H. Goch, 
  • Page: 21
  • First Published: 11 December 2008
Free Access

93 Increased plasma levels of Osteopontin predict mortality in patients with heart failure

M. Rosenberg,  C. Zugck,  M. Nelles,  E. Giannitsis,  A. Remppis,  H.A. Katus,  N. Frey, 
  • Page: 21
  • First Published: 11 December 2008
Free Access

94 The use of collagen-derived serum peptides in the prognosis of chronic heart failure

D.N. Tziakas,  G.K. Chalikias,  D.A. Stakos,  S.V. Chatzikyriakou,  A. Thomaidi,  A.E. Lantzouraki,  E. Maltezos, 
  • Pages: 21-22
  • First Published: 11 December 2008
Free Access

95 Additive prognostic value of self-rating depression scores and plasma B-type natriuretic peptide in chronic heart failure

M. Nikolaou,  J.T. Parissis,  D. Farmakis,  V. Bistola,  V. Gogas,  G. Filippatos,  D. Kremastinos, 
  • Page: 22
  • First Published: 11 December 2008
Free Access

96 Concomitant estimation of NT-pro-BNP and CA125 for better outcome prognosis in congestive heart failure

K.J. Filipiak,  A. Folga,  M. Grabowski,  S. Szmit,  R. Glowczynska,  A. Budaj,  M. Marchel,  G. Opolski, 
  • Page: 22
  • First Published: 11 December 2008
Free Access

97 Hierarchical analysis of dietary habits in relation to cardiovascular disease events, in patients with heart failure: a 12-month follow-up

C. Chrysohoou,  G. Pounis,  I. Kotroyiannis,  C. Pitsavos,  L. Papademetriou,  P. Aggelopoulos,  G. Triantafyllou,  C. Stefanadis, 
  • Pages: 22-23
  • First Published: 11 December 2008
Free Access

99 Supra-regional success of a structured training program for general practitioners enabling performance of handheld echocardiography and point-of-care BNP testing and use for heart failure diagnosis

C. Hoyer,  S. Guenther,  C. Rost,  S. Stoerk,  T. Buck,  R. Erbel,  G. Ertl,  C.E. Angermann,  on behalf of German Heart Failure Network of Competence , 
  • Page: 23
  • First Published: 11 December 2008
Free Access

100 Clinical and diagnostic importance of Tei index in patients above age 60 years with chronic heart failure

B. Bart,  V. Larina,  M. Alekhin,  J. Bart, 
  • Page: 23
  • First Published: 11 December 2008
Free Access

101 Diagnostic difficulty with new onset heart failure in the community. A modest improvement over time but ongoing need for specialist assessment

G. Mak,  M. Ryder,  C. O'Loughlin,  C. Conlon,  M. Ledwidge,  D. McCaffrey,  K. Mcdonald, 
  • Pages: 23-24
  • First Published: 11 December 2008
Free Access

102 Immunohistological detection of parvovirus B19 VP1- and VP2-capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients

F. Escher,  U. Kuehl,  D. Lassner,  L. Suckau,  W.C. Poller,  H.P. Schultheiss,  M. Noutsias, 
  • Page: 24
  • First Published: 11 December 2008
Free Access

103 Routine assessment of iron status in all patients with heart failure may identify those at risk of developing anaemia

C.L. Murphy,  E.J. Fitzsimons,  A.J. Jardine,  N. Sattar,  J.J.V. McMurray, 
  • Page: 24
  • First Published: 11 December 2008
Free Access

104 New steps towards heart failure identification in asymptomatic patients undergoing a screening protocol using computed tomography

H. Kaelsch,  T. Neumann,  S. Moehlenkamp,  S. Moebus,  K. Mann,  K.-H. Joeckel,  R. Erbel, 
  • Pages: 24-25
  • First Published: 11 December 2008
Free Access

106 MMP-9 and TIMP-1 in different types of left ventricle overload in patients with heart valve disease

N.S. Goncharova,  O.M. Moiseeva,  G.M. Aleshina,  E.V. Shlyakhto, 
  • Page: 25
  • First Published: 11 December 2008
Free Access

107 1000 pericardial valves in aortic position: determinants of in hospital congestive heart failure

W. Mistiaen,  P. Van Cauwelaert,  P. Muylaert,  E. De Worm, 
  • Page: 25
  • First Published: 11 December 2008
Free Access

108 Distinct down-regulation of C-type natriuretic peptide system in human aortic valve stenosis

T.O. Peltonen,  P. Taskinen,  Y. Soini,  J. Rysa,  P. Ohtonen,  T. Juvonen,  H. Ruskoaho,  H. Leskinen,  on behalf of Department of Pharmacology and Toxicology, Biocenter Oulu, University of Oulu, Oulu, Finland , 
  • Page: 26
  • First Published: 11 December 2008
Free Access

109 Early effects of mitral valve repair in patients with left ventricular dysfunction: an echocardiographic study

C. Rostagno,  S. Caciolli,  G.F. Fradella,  P.L. Stefano, 
  • Page: 26
  • First Published: 11 December 2008
Free Access

110 The promoter activity of matrix metalloproteinase-3 gene is associated with left ventricular remodelling and regurgitation in Mitral Valve Prolapse patients

D. Oceandy,  R. Yussoff,  S.G. Ray,  F.M. Baudoin,  L. Neyses, 
  • Page: 26
  • First Published: 11 December 2008
Free Access

112 ApoE polymorphism in dilated cardiomyopathy and advanced heart failure

E. Goncalvesova,  D. Jurkovicova,  B. Sedlakova,  S. Hudecova,  M. Luknar,  O. Krizanova, 
  • Page: 27
  • First Published: 11 December 2008
Free Access

113 Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure

S. Nodari,  M. Metra,  G. Milesi,  D. Fumagalli,  A. Manerba,  P. Rocca,  D. Maffeo,  L. Dei Cas, 
  • Page: 27
  • First Published: 11 December 2008
Free Access

114 Different prognostic values of clinical and metabolic parameters in ischaemic diabetic patients with preserved/impaired left ventricular function

S. Nodari,  D. Fumagalli,  A. Manerba,  A. Vaccari,  G. Seresini,  A. Dei Cas,  M. Metra,  L. Dei Cas, 
  • Pages: 27-28
  • First Published: 11 December 2008
Free Access

115 Combination-therapy with neutralizing cyclopeptides and beta-blockers decreases molecular markers of sympathetic activation and reverses cardiomyopathy in beta1-receptor antibody-induced heart failure

V. Boivin,  D. Palm,  R.J. Frost,  L. Hein,  C.E. Angermann,  G. Ertl,  M.J. Lohse,  R. Jahns, 
  • Page: 28
  • First Published: 11 December 2008
Free Access

116 Right ventricular contractile reserve in hypertrophic and dilated cardiomyopathy

G. Plehn,  C.H. Perings,  J. Vormbrock,  I. Wickenbrock,  C.H. Zuehlke,  H.J. Trappe, 
  • Page: 28
  • First Published: 11 December 2008
Free Access

117 Ischaemic dilated cardiomyopathy without mitral regurgitation

M. Di Donato,  S. Castelvecchio,  F. Fantini,  Y. Brancovic,  L. Menicanti, 
  • Pages: 28-29
  • First Published: 11 December 2008
Free Access

118 NT-proBNP values and Weber functional class classification in patients with chronic heart failure

R.M. Fernandes,  R.M. Soares,  J. Feliciano,  J. Serra,  A. Mamede,  R. Ramos,  A. Abreu,  R. Ferreira, 
  • Page: 29
  • First Published: 11 December 2008
Free Access

119 Lamina-associated polypeptide 2, lamin A and p62 expression in ischemic and dilated cardiomyopathy

R. Cortes,  M. Portoles,  E. Rosello,  L. Martinez Dolz,  L. Almenar,  A. Salvador,  V. Bertomeu,  M. Rivera Otero, 
  • Page: 29
  • First Published: 11 December 2008
Free Access

120 Effects of immunomodulatory therapy on chronic Parvovirus B19 dilated cardiomyopathy and myocarditis on the six minute walk test, serum brain natriuretic peptide and stress echocardiography

E. Okocha,  B. Maisch,  R. Funck,  S. Pankuweit,  J.N.A. Ajuluchukwu,  B.N. Okeahialam,  K.M. Osaji, 
  • Pages: 29-30
  • First Published: 11 December 2008
Free Access

122 Initial experience of sildenafil use in acute reduction of pulmonary arterial hypertension in advanced heart failure patients: comparison between two different protocols

A. Freitas Jr,  F. Bacal,  L.F.P. Moreira,  A.I. Fiorelli,  R. Honorato,  J.L. Oliveira Jr,  N.A.G. Stolf,  E.A. Bocchi, 
  • Page: 30
  • First Published: 11 December 2008
Free Access

123 Prevalence of pulmonary arterial hypertension and echocardiographic signs of right heart failure in HIV infected patients

C. Buhr,  N. Reinsch,  P. Krings,  H. Kaelsch,  T. Konorza,  T. Neumann,  R. Erbel,  on behalf of German Heart Failure Network , 
  • Page: 30
  • First Published: 11 December 2008
Free Access

124 Recovery of right ventricular function and clinical improvement in patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy

S. Ghio,  A.M. D'armini,  G. Magrini,  C. Klersy,  G. Zanotti,  C. Falcone,  M. Vigano,  L. Tavazzi, 
  • Pages: 30-31
  • First Published: 11 December 2008
Free Access

125 Effective arterial elastance as an index of pulmonary arterial load

P. Morimont,  B. Lambermont,  A. Ghuysen,  P. Lancellotti,  V. Tchana-Sato,  P. Kolh,  V. D'orio,  L.A. Pierard, 
  • Page: 31
  • First Published: 11 December 2008
Free Access

126 Combined inhibition of tyrosine- and serine-/threonine kinases in pulmonary hypertension: Sorafenib prevents vascular and myocardial remodeling

M. Klein,  W. Janssen,  P. Ellinghaus,  B. Riedl,  F. Grimminger,  R.T. Schermuly,  S. Schaefer, 
  • Page: 31
  • First Published: 11 December 2008
Free Access

127 Gender differences in HIV-related pulmonary hypertension - results from the HIV-HEART Study

N. Reinsch,  C. Buhr,  T. Konorza,  P. Krings,  H. Kaelsch,  T. Neumann,  R. Erbel,  on behalf of German Heart Failure Network , 
  • Pages: 31-32
  • First Published: 11 December 2008
Free Access

129 A characteristic and potentially diagnostic abnormality of systolic myocardial deformation at Doppler myocardial imaging in patients with hypertrophic cardiomyopathy

S. Ghio,  M. Revera,  C. Klersy,  M. Pasotti,  A. Serio,  E. Arbustini,  L. Scelsi,  L. Tavazzi, 
  • Page: 32
  • First Published: 11 December 2008
Free Access

130 Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration

C. Chimenti,  R. Verardo,  M.C. Acconcia,  M. Caldarulo,  M.A. Russo,  A. Frustaci, 
  • Page: 32
  • First Published: 11 December 2008
Free Access

131 Right heart impairment in children and in adults with hypertrophic obstructive cardiomyopathy

L.A. Bokeria,  A.Y. Gudkova,  E.N. Semernin,  A.N. Krutikov,  E.A. Lokhmatova,  K.V. Borisov,  E.V. Shlyakhto, 
  • Pages: 32-33
  • First Published: 11 December 2008
Free Access

132 Longitudinal strain rate/strain and coronary flow velocity in patients with hypertrophic cardiomyopathy

E. Pavlyukova,  R. Karpov, 
  • Page: 33
  • First Published: 11 December 2008
Free Access

133 Prospects of beta-blocker nebivolol application in patients with hypertrophic cardiomyopathy

Z.M. Musayev,  R. Valiyev,  E. Rafibeyli,  A. Dadasheva, 
  • Page: 33
  • First Published: 11 December 2008
Free Access

134 Prognostic value of relationships between BNP and left ventricle structure and function in patients with hypertrophic cardiomyopathy

Z. Oko-Sarnowska,  H. Wachowiak-Baszynska,  E. Straburzynska-Migaj,  A. Katarzynska-Szymanska,  O. Trojnarska,  A. Baszczuk,  P. Mitkowski,  A. Szyszka, 
  • Pages: 33-34
  • First Published: 11 December 2008
Free Access

135 Stromal area and level of disarray in myocardium in patients with hypertrophic obstructive cardiomyopathy

A.Y. Gudkova,  E.V. Shlyakhto,  K.V. Borisov,  L.A. Bokeria, 
  • Page: 34
  • First Published: 11 December 2008
Free Access

136 Usefulness of Tissue Doppler Imaging in predicting the clinical course of patients with hypertrophic cardiomyopathy

F. Bayrak,  G. Kahveci,  B. Mutlu,  M. Degertekin,  E. Demirtas, 
  • Page: 34
  • First Published: 11 December 2008
Free Access

138 Microalbuminuria and extracellular matrix changes in primary hypertension

N.V. Belaya, 
  • Pages: 34-35
  • First Published: 11 December 2008
Free Access

139 Myocardial stabilization of beta-catenin abrogates adaptive cardiac hypertrophy in vivo

L. Zelarayan,  A. Baurand,  C. Gehrke,  S. Dunger,  R. Dietz,  M.W. Bergmann, 
  • Page: 35
  • First Published: 11 December 2008
Free Access

140 The effects of an aging vascular model on healthy and diseased hearts

D. Jegger,  R. Da Silva,  I. Lartaud,  X. Jeanrenaud,  J. Atkinson,  P. Segers,  H.T. Tevaearai,  N. Stergiopulos, 
  • Page: 35
  • First Published: 11 December 2008
Free Access

141 Treatment of hypertensive patients and moderate heart failure with selective adrenoblocker Nebivolol

K. Nikoghosyan,  S. Gurgenyan,  S. Vatinian,  on behalf of Institute of Cardiology, Department of Arterial Hypertension , 
  • Pages: 35-36
  • First Published: 11 December 2008
Free Access

143 Comparison of five echocardiographic methods for the assessment of diastolic dysfunction

P. Jung,  H.Y. Sohn,  J. Rieber,  S. Schmieder,  A. Koenig,  V. Klauss, 
  • Page: 36
  • First Published: 11 December 2008
Free Access

144 Impact of sinvastatin on left ventricular diastolic dysfunction: results of randomized study

E.A. Marsaro,  D.L. Dias,  W. Nadruz Jr,  K.G. Franchini,  O.R. Coelho, 
  • Page: 36
  • First Published: 11 December 2008
Free Access

145 Factors determining use of statin therapy in patients with heart failure and preserved left ventricular function

M. Roik,  M.H. Starczewska,  S. Stawicki,  J. Kochanowski,  P. Scislo,  Z. Huczek,  G. Opolski, 
  • Pages: 36-37
  • First Published: 11 December 2008
Free Access

146 Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive diastolic pattern

M. Feola,  N. Aspromonte,  G.L. Rosso,  R. Ricci,  L. Milani,  R. Valle, 
  • Page: 37
  • First Published: 11 December 2008
Free Access

147 The effects of hormone replacement therapy on diastolic function in postmenopausal women

H. Duygu,  L. Akman, 
  • Page: 37
  • First Published: 11 December 2008
Free Access

148 Diastolic dysfunction and functional mitral regurgitation are the main determinants of abnormal cardiopulmonary stress test in elderly patients with systolic heart failure

C. Bizzi,  G. Malfatto,  G. Branzi,  F. Ciambellotti,  M. Facchini, 
  • Pages: 37-38
  • First Published: 11 December 2008
Free Access

149 The acute decrease of myocardial stiffness induced by beta-adrenergic stimulation is independent of the endocardial endothelium and prostaglandins release

A.P. Fontes-Sousa,  I. Falcao-Pires,  C. Bras-Silva,  A.F. Leite-Moreira, 
  • Page: 38
  • First Published: 11 December 2008
Free Access

150 Effect of spironolactone therapy in patients with impaired diastolic function

H. Ozhan,  Y. Balaban,  S. Albayrak,  A. Kaya,  S. Ordu,  S. Sozen,  M. Yazici, 
  • Page: 38
  • First Published: 11 December 2008
Free Access

151 Left atrial truncated cone volume to detect left ventricular diastolic heart failure

D.C. Cozma,  L. Petrescu,  R. Dan,  S.I. Dragulescu, 
  • Pages: 38-39
  • First Published: 11 December 2008
Free Access

152 Exercise tolerance and diastolic dysfunction in patients with insulin resistance

H. Adachi,  K. Taniguchi,  K. Taniguchi, 
  • Page: 39
  • First Published: 11 December 2008
Free Access

153 Correlation of diastolic function and sympathetic activation in systolic heart failure patients without beta-blocker therapy

E.T. Mesquita,  C.T. Mesquita,  H.J. Dohmann,  S.M. Miranda,  J.C. Azevedo, 
  • Page: 39
  • First Published: 11 December 2008
Free Access

154 Urocortin 2 acutely decreases myocardial stiffness

C. Bras-Silva,  A.J. Duarte,  D. Monteiro-Sousa,  A.F. Leite-Moreira, 
  • Pages: 39-40
  • First Published: 11 December 2008
Free Access

155 Diastolic left ventricular dysfunction in patients with subclinical hypothyroidism. Effects of thyrohormone treatment

C. Lafaras,  D. Platogiannis,  E. Mandala,  N. Barbetakis,  T. Bischiniotis, 
  • Page: 40
  • First Published: 11 December 2008
Free Access

156 NT-proBNP predicts cardiovascular outcomes in patients with heart failure and preserved ejection fraction

J. Grewal,  E. Lonn,  P. Tait,  J. Carlson,  R. McKelvie,  H. Persson, 
  • Page: 40
  • First Published: 11 December 2008
Free Access

157 Relevance of atrioventricular remodelling indices on assessment of left ventricle diastolic function in a population with LV preserved systolic function and heart failure

L.C. Danzmann,  I. Kohler,  D.C. Roso,  T.V. Branchi,  V. Freitas,  M.A.R. Torres, 
  • Pages: 40-41
  • First Published: 11 December 2008
Free Access

158 Impact of diastolic function changes during stress echocardiography on exercise tolerance in ischemic heart failure patients

P. Rubis,  P. Podolec,  L. Tomkiewicz-Pajak,  G. Kopec,  W. Tracz, 
  • Page: 41
  • First Published: 11 December 2008
Free Access

159 Central obesity is an independent risk factor for impaired left ventricular diastolic function

B. Juzal,  W. Braksator,  M. Dluzniewska,  A. Mamcarz,  M. Kuch,  M. Dluzniewski, 
  • Page: 41
  • First Published: 11 December 2008
Free Access

160 Diastolic asynchrony estimation in hypertensive patients with left ventricular diastolic dysfunction and normal QRS duration

A. Stevanovic,  M. Dekleva, 
  • Page: 41
  • First Published: 11 December 2008
Free Access

161 Improvement in left ventricular diastolic elastance induced by physical training in patients with heart failure

G. Malfatto,  P. Valli,  G. Osculati,  F. Ciambellotti,  M. Facchini,  G. Branzi,  G. Parati, 
  • Page: 42
  • First Published: 11 December 2008
Free Access

162 Significance and prognostic value of QRS duration in heart failure with preserved ejection fraction

P. Nijjar,  G. Ngarmchamnanrith,  H. Ra,  R. Ishac,  A. Stewart,  D. Karia, 
  • Page: 42
  • First Published: 11 December 2008
Free Access

184 Tetrahydrobiopterin reverses pressure-load induced remodeling by recoupling of eNOS

A. Moens,  G. Tocchetti,  E. Takimoto,  E. Ketner,  K. Chakir,  A. Haile,  H. Champion,  D. Kass, 
  • Page: 43
  • First Published: 11 December 2008
Free Access

185 Abnormal electrical function of the heart caused by loss of integrin alpha 7 gene

R. Nadif-Savey,  E.J. Cartwright,  M. Emerson,  C. Guo,  U. Mayer,  L. Neyses, 
  • Page: 43
  • First Published: 11 December 2008
Free Access

186 IGF-I prevents TNF-alpha-induced atrogin-1 gene expression in C2C12 myotubes

I. Plaisance,  C. Morandi,  C. Murigande,  M. Brink, 
  • Page: 44
  • First Published: 11 December 2008
Free Access

187 Angiotensin-induced hypertrophy of H9C2-cells is prevented by activation of AMP-activated protein kinase (AMPK)

B.J. Stuck,  M. Lenski,  M. Bohm,  U. Laufs, 
  • Page: 44
  • First Published: 11 December 2008
Free Access

188 Calsarcin-1 inhibits Angiotensin-II induced cardiac hypertrophy in vivo and in vitro

D. Frank,  C. Kuhn,  M. Van Eickels,  D. Gehring,  H.A. Katus,  N. Frey, 
  • Pages: 44-45
  • First Published: 11 December 2008
Free Access

189 Extracellular S100A1 protein modulates cardiac matrix gene expression through activation of the MAPK - NF-kappaB signalling pathway

D. Rohde,  M. Boerries,  S.T. Pleger,  P.P. Nawroth,  H.A. Katus,  W.J. Koch,  A. Bierhaus,  P. Most, 
  • Page: 45
  • First Published: 11 December 2008
Free Access

244 Derivation and validation of a clinical risk-model in heart failure based on 6-min walk test performance and NT-proBNP status

L. Frankenstein,  L. Ingle,  A. Remppis,  D. Schellberg,  C. Sigg,  M. Nelles,  H. Katus,  C. Zugck, 
  • Page: 46
  • First Published: 11 December 2008
Free Access

245 Prognostic utility of growth-differentiation factor-15 in patients with chronic heart failure

T. Kempf,  S. Von Haehling,  M. Cicoira,  P. Ponikowski,  G.S. Filippatos,  P. Rozentryt,  S.D. Anker,  K.C. Wollert, 
  • Pages: 46-47
  • First Published: 11 December 2008
Free Access

246 Structural alterations of large intestinal wall is a possible cause of systemic inflammation in patients with chronic heart failure of different classes

N.A. Bylova,  G.P. Arutyunov,  L.I. Kafarskaya,  N.A. Savelov,  T.K. Chernyavskaya,  Y.A. Pokrovsky,  N.V. Kokosadze,  A.B. Risnenko, 
  • Page: 47
  • First Published: 11 December 2008
Free Access

247 Estimated glomerular filtration rate and the cardio-renal index predict outcome in patients with chronic heart failure

A. Vazir,  A. Bolger,  R. Kaprielian,  C. Chapman, 
  • Page: 47
  • First Published: 11 December 2008
Free Access

248 The mobilization of CD34+ and CD133+ bone marrow-derived circulating progenitor cells and their correlation with the left ventricular function as well as the infarct size following AMI

R.G. Turan,  M. Brehm,  M. Koestering,  T. Zeus,  T. Bartsch,  S. Yokus,  C.M. Schannwell,  B.E. Strauer, 
  • Pages: 47-48
  • First Published: 11 December 2008
Free Access

249 Immune-mediated dysregulation of cellular iron transport proteins as the molecular basis of defective iron homeostasis in chronic heart failure

D.O. Okonko,  J. Dave,  P. Taylor,  S.D. Anker,  P.A. Poole-Wilson, 
  • Page: 48
  • First Published: 11 December 2008
Free Access

251 Are disease management programmes cost-effective for all elderly patients with heart failure? Usefulness of frailty profile in selection process, a randomised study

G. Pulignano,  D. Del Sindaco,  A. Di Lenarda,  L. Tarantini,  G. Cioffi,  C. Manzara,  D. Gregori,  G. Minardi, 
  • Page: 49
  • First Published: 11 December 2008
Free Access

252 Treatment seeking behaviour and factors causing hospital admission in elderly patients with heart failure

A. Stromberg,  J. Martensson,  B. Fridlund,  U. Dahlstrom, 
  • Pages: 49-50
  • First Published: 11 December 2008
Free Access

253 Reduced readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision

N. Aspromonte,  P. Giovinazzo,  F. Noventa,  S. Barro,  A.B. Scardovi,  T. Di Giacomo,  L. Milani,  R. Valle, 
  • Page: 50
  • First Published: 11 December 2008
Free Access

254 Prospective study of an out-patient based intravenous diuretic programme for acute decompensated heart failure

M. Ryder,  D. McCaffrey,  C. O'Loughlin,  C. Conlon,  M. Ledwidge,  K. Mcdonald, 
  • Page: 50
  • First Published: 11 December 2008
Free Access

255 Salt and water restriction in patients with chronic heart failure

H. Philipson,  K. Swedberg,  I. Ekman,  M. Schaufelberger, 
  • Pages: 50-51
  • First Published: 11 December 2008
Free Access

257 Different prognostic relevance of left ventricular volumes and ejection fraction in heart failure patients with ischemic or non ischemic aetiology: a meta analysis

S. Ghio,  P.L. Temporelli,  N. Ajmone Marsan,  K. Poppe,  R. Doughty,  P. Giannuzzi,  L. Tavazzi,  G. Whalley,  on behalf of MERGE-HF collaborators , 
  • Page: 51
  • First Published: 11 December 2008
Free Access

258 Ambulatory monitoring for heart failure patients: it is possible to improve survival and quality of life: a metanalysis of randomized controlled trials

F. Canario-Almeida,  L. Azevedo,  A. Costa-Pereira, 
  • Page: 51
  • First Published: 11 December 2008
Free Access

259 Familial dilated cardiomyopathy in an outpatient heart failure clinic

E. Martins,  J. Silva-Cardoso,  M. Campelo,  S. Amorim,  B. Moura,  F. Rocha-Goncalves,  M.J. Maciel, 
  • Page: 51
  • First Published: 11 December 2008
Free Access

260 Prognostic value of serum sodium concentration in outpatients with chronic heart failure. Data from IN-CHF Database

S. Baldasseroni,  F. Orso,  L. Gonzini,  P. Midi,  F. Pozzar,  R. Urso,  M.G. Vincenti,  A.P. Maggioni,  on behalf of IN-CHF Investigators , 
  • Page: 52
  • First Published: 11 December 2008
Free Access

261 QT variability and cardiovascular risk in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction

G. Piccirillo,  F. Barillà,  D. Magri,  E. Schifano,  S. Bianchi,  S. Matera,  M. Magnanti,  R. Quaglione, 
  • Page: 52
  • First Published: 11 December 2008
Free Access

262 A one year follow-up of patients for post-myocardial infarction left-ventricular dysfunction: assessment of changes in LV performance and exercise capacity after early PCI or conservative treatment

W. Pawlowska-Jenerowicz,  W. Lechowicz,  M. Dabrowski, 
  • Pages: 52-53
  • First Published: 11 December 2008
Free Access

263 Microalbuminuria in congestive heart failure; valid and independent marker of cardiovascular disease

V. Raos-Plenkovic,  T. Katic,  B. Vitunjski-Englert,  O. Jaksic,  M. Raguz,  J. Sikic-Vagic,  M. Bergovec, 
  • Page: 53
  • First Published: 11 December 2008
Free Access

264 Factors relating to hospital readmissions in patients with heart failure

T.H. Livieratos,  A.R. Tziovas,  A.L. Patsilinakos,  M.A. Dibritsioti,  G.E. Kordosis,  A.T.H. Germanos, 
  • Page: 53
  • First Published: 11 December 2008
Free Access

265 Correlation of hyponatremia with plasma renin activity antidiuretic hormone and brain natriuretic peptide in chronic heart failure

L. Fu,  H. Ge,  on behalf of Harbin Medical University , 
  • Page: 53
  • First Published: 11 December 2008
Free Access

266 Relative study between left ventricular asynchrony and ventricular arrhythmias in patients with chronic heart failure

L. Fu,  G. Chen,  on behalf of Harbin Medical University , 
  • Page: 54
  • First Published: 11 December 2008
Free Access

267 Inflammatory markers (TNF-alpha, IL-6,CRP), BNP and cardiopulmonary stress test parameters in patients with heart failure and atrial fibrillation

J. Nessler,  B. Nessler,  M. Kitlinski,  D. Mroczek-Czernecka,  A. Pietrucha,  A. Gackowski,  W. Piwowarska, 
  • Page: 54
  • First Published: 11 December 2008
Free Access

268 Should we be cautious when recommending exercise in patients with chronic heart failure?

E. Saeed,  S. Leonard,  J. Davidson,  A. Cunningham,  N. Daly,  H. Melanson,  P. Marsden,  P. Shiels,  on behalf of Cardiac Department, Tullamore Regional Hospital, Ireland , 
  • Page: 54
  • First Published: 11 December 2008
Free Access

269 From nurse-led heart failure clinic to device therapy - an important step for patients in the management of their heart failure

S.W. Murray,  A.P. Mann,  C. Mottram,  P.A. Dodds, 
  • Page: 55
  • First Published: 11 December 2008
Free Access

270 Pulmonary thromboembolism in patients with chronic heart failure

G. Arutyunov,  A. Rozanov,  S. Khokhlova,  K. Rogov, 
  • Page: 55
  • First Published: 11 December 2008
Free Access

271 Studying the effect of long-term dosed exercise on the level of systemic inflammation markers in patients with II-III FC CHF

G. Arutyunov,  T. Cherniavskaya,  O. Volgina, 
  • Page: 55
  • First Published: 11 December 2008
Free Access

272 Mortality in patients with heart failure is associated with lower body weight and functional capacity independent of LV function and weight changes

S. Fall,  M. Carey,  S. Tekle,  B.U. Khan,  M. Habib,  T. Kiernan,  E. Ho,  V. Maher, 
  • Page: 55
  • First Published: 11 December 2008
Free Access

273 Role of the combination of multiple clinical, laboratory and instrumental parameters in risk assessment of patients with chronic heart failure

A.B. Scardovi,  R. De Maria,  C. Coletta,  N. Aspromonte,  S. Perna,  G. Cacciatore,  R. Ricci,  V. Ceci, 
  • Page: 56
  • First Published: 11 December 2008
Free Access

274 Telemonitoring or structured telephone support programs for patients with heart failure: a systematic review and meta-analysis

R.A. Clark,  S.C. Inglis,  F.A. Mcalister,  J.G.F. Cleland,  S. Stewart, 
  • Page: 56
  • First Published: 11 December 2008
Free Access

275 Personalized tele-guidance of heart failure patients. Effects of the MOTIVA interactive health care platform on hospital admissions, quality of life, knowledge of disease and self-care. A pilot study

A.H.M.M. Balk,  C.M. Leenders,  W. Davidse,  C. Westerteicher,  G. Montfort Van, 
  • Page: 56
  • First Published: 11 December 2008
Free Access

276 Oxidative stress level correlates with clinical parameters in chronic heart failure patients

O. Amir,  R.E. Amir,  H. Paz,  O. Rogowski,  S. Shnizer,  R. Ammar,  M. Sagiv,  B.S. Lewis, 
  • Page: 57
  • First Published: 11 December 2008
Free Access

277 Rhythm control strategy improves exercise tolerance and left ventricular function in patients with persistent atrial fibrillation

D.A. Kosior,  J. Kochanowski,  P. Scislo,  M. Marchel,  S. Stawicki,  M. Roik,  G. Opolski, 
  • Page: 57
  • First Published: 11 December 2008
Free Access

278 Cystatina C is a strong predictor of a new onset heart failure in acute coronary syndrome patients

J.M. Garcia Acuna,  E. Gonzalez Babarro,  A.M. Lopez Lago,  R. Vidal Perez,  E. Abu Assi,  B. Cid Alvarez,  C. Pena Gil,  J.R. Gonzalez-Juanatey, 
  • Pages: 57-58
  • First Published: 11 December 2008
Free Access

279 Metabolic Syndrome (MetS) in elderly with heart failure: how much does it really matter? - Clinical aspects, practical involvements

D. Toporan,  C. Tanaseanu,  M.M. Vintila, 
  • Page: 58
  • First Published: 11 December 2008
Free Access

280 Influence of heart disease and left ventricular ejection fraction on the incidence of malignant ventricular tachycardias in patients receiving Cardiac Resynchronization Therapy

J. Kreuz,  O. Balta,  N. Lilegren,  G. Nickenig,  J.O. Schwab, 
  • Page: 58
  • First Published: 11 December 2008
Free Access

281 Intrathoracic impedance monitoring in heart failure: a preliminary experience in outpatient setting

L. Zanolla,  L. Tomasi,  G. Zanotto,  C. Cocco,  G. Golia,  G. Morani,  F. Cesarotto,  C. Vassanelli, 
  • Pages: 58-59
  • First Published: 11 December 2008
Free Access

282 Prognostic value of exercise time in children with chronic heart failure: one year follow-up

G. Guimaraes,  A. Mocelin,  P. Camargo,  E. Bocchi, 
  • Page: 59
  • First Published: 11 December 2008
Free Access

283 Generic health-related quality of life in patients with chronic systolic heart failure: impact of depression

C. Angermann,  S. Stork,  G. Gelbrich,  J.P. Langguth,  M. Schowalter,  H. Faller,  G. Ertl,  on behalf of INH-Study Group of the German Heart Failure Network of Competence , 
  • Page: 59
  • First Published: 11 December 2008
Free Access

284 Non-cardiovascular mortality in patients assisted in a multidisciplinary Heart Failure Unit

A. Urrutia,  J. Lupon,  B. Gonzalez,  D. Mas,  M. Domingo,  R. Coll,  S. Altimir,  V. Valle, 
  • Pages: 59-60
  • First Published: 11 December 2008
Free Access

285 Heart failure units in Spain: State of the art

E. Zamora,  J. Lupon, 
  • Page: 60
  • First Published: 11 December 2008
Free Access

286 Predictors of glomerular filtration rate in congestive heart failure dependent of age

B. Waldum,  M. Grundtvig,  A. Westheim,  T. Hole,  L. Gullestad,  I. Os, 
  • Page: 60
  • First Published: 11 December 2008
Free Access

287 Metabolic syndrome in chronic heart failure: prevalence and relation to clinical features and aetiology

C.S. Minneci,  P. Perrone Filardi,  R. Marchioli,  M.G. Rossi,  E. Carbonieri,  R. Latini,  A.P. Maggioni,  L. Tavazzi,  on behalf of GISSI-HF Investigators , 
  • Page: 61
  • First Published: 11 December 2008
Free Access

288 Prevalence and determinants of depression in chronic systolic heart failure

S. Stork,  G. Gelbrich,  C. Hoyer,  M. Schowalter,  H. Faller,  G. Ertl,  C. Angermann,  on behalf of INH-Study Group of the German Heart Failure Network of Competence , 
  • Page: 61
  • First Published: 11 December 2008
Free Access

289 Telemonitoring by congestive heart failure: Predictive value of blood pressure and weight instability in the early detection of pending cardial decompensation

D. Baden,  J. Fleck,  M. Klingelberg,  M. Waehner,  C.H. Zugck,  H. Korb, 
  • Pages: 61-62
  • First Published: 11 December 2008
Free Access

290 Beta-blockers impact on sleep disordered breathing in chronic heart failure

E. Vermes,  T. Damy,  O. Jobart,  F. Yacoubi,  C. Philippe,  F. Roudot Thoraval,  M.P. D'ortho,  L. Hittinger, 
  • Page: 62
  • First Published: 11 December 2008
Free Access

291 Accuracy of intrathoracic impedance monitoring in detecting acute decompensation of chronic heart failure

M. Iacoviello,  V. Giannoccaro,  M. Moramarco,  M. Anaclerio,  C. Forleo,  G. Luzzi,  P. Guida,  S. Favale, 
  • Page: 62
  • First Published: 11 December 2008
Free Access

292 Screening for sleep related breathing disorders in patients with chronic heart failure during cardiac rehabilitation

E. Skobel,  P. Redanz,  S. Schenck,  O. Henssen,  A. Jendralski, 
  • Page: 62
  • First Published: 11 December 2008
Free Access

293 Late beneficial effects of a disease program management on mortality, hospitalisation, and quality of life in heart failure patients

E.A. Bocchi,  F. Cruz,  G. Guimaraes,  F. Bacal,  G. Dousa,  V. Issa,  S. Ferreira,  P. Chizzola, 
  • Page: 63
  • First Published: 11 December 2008
Free Access

295 Staged telemedical service for patients with mild-to-moderate congestive heart failure

A.J. Morguet,  P. Kuehnelt,  A. Kallel,  M. Jaster,  H.P. Schultheiss, 
  • Page: 63
  • First Published: 11 December 2008
Free Access

296 NHS Heart Failure Survey - Acute heart failure admissions in England, Wales and Northern Ireland - Cardiovascular status, management and length of stay

E.D. Nicol,  B. Fittal,  M. Roughton,  H. Dargie,  J.G.F. Cleland,  M. Cowie,  on behalf of Healthcare Commission and British Society for Heart Failure , 
  • Pages: 63-64
  • First Published: 11 December 2008
Free Access

297 Management of patients with heart failure in a regional hospital: comparison of cardiologists and internists

L. Hodoscek,  M. Lainscak, 
  • Page: 64
  • First Published: 11 December 2008
Free Access

299 Relation between self-care behaviors and self-care needs in patients with heart failure, 2006

M. Azarbad,  F. Shahpourian,  Z. Mohammadaliha,  F. Rafiee, 
  • Page: 64
  • First Published: 11 December 2008
Free Access

300 Adherence to medical therapy and self monitoring in heart failure patients: Findings and impact of a nurse-based home care programme (Kardiomobil)

J. Altenberger,  J. Kraus,  M. Matzinger,  J. Eichinger, 
  • Pages: 64-65
  • First Published: 11 December 2008
Free Access

301 Are depressive symptoms an independent risk for cardiovascular mortality? Results from elderly patients in primary care with symptoms of heart failure followed during six years

P. Johansson,  U. Dahlstrom,  U. Alehagen, 
  • Page: 65
  • First Published: 11 December 2008
Free Access

302 The natural history of acute heart failure in chronic heart failure

S.C. Inglis,  J.D. Horowitz,  S. Stewart, 
  • Page: 65
  • First Published: 11 December 2008
Free Access

303 Patients with implantable cardioverter defibrillator and their experiences of shocks

A. Stromberg,  J. Hammargard,  D. Fant,  I. Johansson, 
  • Page: 66
  • First Published: 11 December 2008
Free Access

304 Driving restrictions during treatment with implantable cardioverter defibrillator: a qualitative analysis

A. Stromberg,  F. Blixt,  F. Andersson,  I. Johansson, 
  • Page: 66
  • First Published: 11 December 2008
Free Access

305 Epidemiology of quality of life, depression and cognitive functioning (QDF) in a cohort of 1564 heart failure patients: a nurse-led study

P. Di Giulio,  V. Lepore,  D. Miani,  G. Tognoni,  on behalf of Network of Nurses of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza cardiaca) Trial , 
  • Pages: 66-67
  • First Published: 11 December 2008
Free Access

306 Impact of new technologies on the clinical care of heart failure patients

L. San Vicente Urondo,  N. Galofre,  J.A. Gonzalez,  E. Galvez,  M. Altimira,  L. Ortega,  D. Fuster,  F. Planas, 
  • Page: 67
  • First Published: 11 December 2008
Free Access

307 Perception of sexual problems in patients with heart failure

B. Gonzalez,  D. Mas,  M. Arenas,  J. Lupon,  A. Urrutia,  M. Domingo,  C. Diez,  V. Valle, 
  • Page: 67
  • First Published: 11 December 2008
Free Access

308 Depressive symptoms and quality of life in heart failure patients compared with community dwelling elderly

I. Lesman-Leegte,  T. Jaarsma,  R. Sanderman,  H. Hillege,  D.J. Van Veldhuisen, 
  • Pages: 67-68
  • First Published: 11 December 2008
Free Access

309 Influence of social demographic factors on mortality after heart transplantation

A. Relbo,  I. Grov,  S. Arora,  A.K. Andreassen,  E. Gude,  S. Simonsen,  L. Gullestad, 
  • Page: 68
  • First Published: 11 December 2008
Free Access

310 Multidisciplinary management of elderly patients with heart failure in a day hospital

N. Munoz Rivas,  M. Mendez,  P. Montejo De Garcini,  A. Yera,  M. Cano,  J. Ortiz,  P. Conthe,  L. Audibert, 
  • Page: 68
  • First Published: 11 December 2008
Free Access

311 Who should assess symptoms, quality of life, and health in heart failure: patient, doctor or nurse?

M. Lainscak,  D. Stevancec,  L. Hodoscek, 
  • Page: 68
  • First Published: 11 December 2008
Free Access

312 5 years on - nurse-led heart failure clinics: hospitalisation and survival

J. Barrett,  S. Terry,  C. Brennan,  H.F. McIntyre, 
  • Page: 69
  • First Published: 11 December 2008
Free Access

314 Low internight variability of sleep disordered breathing in stable heart failure

O. Oldenburg,  B. Lamp,  J. Wedewardt,  B. Muntean,  K. Freivogel,  D. Horstkotte, 
  • Page: 69
  • First Published: 11 December 2008
Free Access

315 Quality of life of the Spanish chronic heart failure patients. The INCA study

B. De Rivas,  B. Permanyer-Miralda,  C. Brotons,  J. Aznar,  E. Sobreviela,  R. Fernandez,  on behalf of INCA investigators , 
  • Pages: 69-70
  • First Published: 11 December 2008
Free Access

316 Effectiveness and tolerability of angiotensin converting enzyme inhibitors in chronic cor pulmonale

G. Gheorghe,  M. Bulandra,  I.T. Nanea, 
  • Page: 70
  • First Published: 11 December 2008
Free Access

317 Safe and reliable monitoring of pulmonary artery pressure in heart failure patients by the RemonCHF device

U.C. Hoppe,  M.C. Brandt,  J. Muller-Ehmsen,  S. Rosenkranz,  H.-W. Hopp,  Y. Rozenman,  E. Erdmann, 
  • Page: 70
  • First Published: 11 December 2008
Free Access

318 Specialist awareness of and adherence to clinical guidelines for management of chronic heart failure (CHF)

M. Komajda,  R. Dietz,  L. Erhardt,  F.D.R. Hobbs,  J. Soler-Soler, 
  • Pages: 70-71
  • First Published: 11 December 2008
Free Access

319 Non invasive cardiac angiogenesis shock wave therapy increases perfusion and exercise tolerance in endstage CAD patients

C. Naber,  T. Ebralidze,  S. Lammers,  G. Hakim,  R. Erbel, 
  • Page: 71
  • First Published: 11 December 2008
Free Access

320 Augmented ventilatory response to CO2 and impaired respiratory stability during exercise in patients with central sleep apnoea and chronic heart failure methods

B.G. Muntean,  J. Wedewardt,  T. Bitter,  B. Lamp,  D. Horstkotte,  O. Oldenburg, 
  • Page: 71
  • First Published: 11 December 2008
Free Access

321 Optimal neurohormonal blockade and statin therapy, the best combination to improve survival in patients with chronic heart failure

M. Roik,  M.H. Starczewska,  J. Kochanowski,  P. Scislo,  G. Opolski, 
  • Pages: 71-72
  • First Published: 11 December 2008
Free Access

322 Depression in elderly patients with congestive heart failure

S. Abou-Raya,  A. Abou-Raya, 
  • Page: 72
  • First Published: 11 December 2008
Free Access

324 Gender bias in treatment of heart failure persists following in-patient admission for acute heart failure

E. Nicol,  B. Fittal,  M. Roughton,  J.G.F. Cleland,  H. Dargie,  M. Cowie,  on behalf of Healthcare Commission and Britsih Society for Heart Failure , 
  • Page: 72
  • First Published: 11 December 2008
Free Access

325 Prevalence, etiology and management of heart failure in patients older than 65 years in Centro Habana, Cuba

J.E. Negrin Exposito,  J.E. Fernandez-Britto Rodriguez, 
  • Pages: 72-73
  • First Published: 11 December 2008
Free Access

326 Rehospitalization in heart failure

R. Musetescu,  D. Toader,  E. Belu,  A.E. Musetescu,  D.D. Ionescu,  on behalf of Zonal Study for Heart Failure in Oltenia County , 
  • Page: 73
  • First Published: 11 December 2008
Free Access

327 Re-hospitalizations and cardiac rehabilitation participation of patients with and without CHF following CABG surgery

G. Geulayov,  D. Gofer,  Y. Drori,  R. Dankner, 
  • Page: 73
  • First Published: 11 December 2008
Free Access

328 Epidemiology of systolic dysfunction in Japan

M. Ramadan,  Y. Ohno,  Y. Okura,  W. Mitsuma,  S. Hirono,  H. Hanawa,  M. Kodama,  Y. Aizawa, 
  • Page: 73
  • First Published: 11 December 2008
Free Access

329 Discrepancies in diagnostics approach between women and men with congestive heart failure in primary care settings registry

R. Glowczynska,  M.E. Starczewska,  A. Pietrasik,  K.J. Filipiak,  G. Opolski, 
  • Page: 74
  • First Published: 11 December 2008
Free Access

330 Care patterns among elderly patients following hospital admission for heart failure in the US

T. Zyczynski,  E. Gemmen,  A. Linnstaedt,  M. Bharmal, 
  • Page: 74
  • First Published: 11 December 2008
Free Access

331 The prevalence of elevated BNP in an asymptomatic population with cardiac risk factors

C. Conlon,  C. O'Loughlin,  A. Patle,  K. Kinch,  A. Whelan,  C. Kelleher,  M. Ledwidge,  K. Mcdonald,  on behalf of The STOP HF Investigators , 
  • Page: 74
  • First Published: 11 December 2008
Free Access

332 Elevated B-type natriuretic peptide is associated with the presence of diastolic abnormalities in an asymptomatic, at-risk community population: The Screening TO Prevent Heart Failure (STOP HF) Study

C. Conlon,  C. O'Loughlin,  A. Patle,  K. Kinch,  A. Whelan,  C. Kelleher,  M. Ledwidge,  K. Mcdonald,  on behalf of the STOP HF Investigators , 
  • Page: 75
  • First Published: 11 December 2008
Free Access

333 Contemporary epidemiology of left ventricular systolic dysfunction after myocardial infarction

A. Torabi,  N.K. Khan,  J.G.F. Cleland, 
  • Page: 75
  • First Published: 11 December 2008
Free Access

334 Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the general population

M. Nakamura,  F. Tanaka,  T. Onoda,  K. Itai,  M. Ohsawa,  K. Kawamura,  A. Okayama,  K. Sakata,  on behalf of Iwate-KENCO Study Group , 
  • Page: 75
  • First Published: 11 December 2008
Free Access

335 Prevalence and predictive factors of heart failure after non ST segment elevation myocardial infarction

O. Barthez,  J.C. Eicher,  M. Zeller,  I. L'huillier,  L. Lorgis,  Y. Cottin,  J.E. Wolf, 
  • Page: 76
  • First Published: 11 December 2008
Free Access

336 The prevalence of asymptomatic left ventricular dysfunction in subjects at risk of heart failure. Results of the PROBE-HF study

G. Castelli,  I. Betti,  A. Barchielli,  C. Beligni,  V. Boscherini,  G. Messeri,  M. Gheorghiade,  A. Zuppiroli, 
  • Page: 76
  • First Published: 11 December 2008
Free Access

337 Special conditions of chronic heart failure in patients with transplanted kidney

O.A. Tronina,  on behalf of Gendlin GE , 
  • Page: 76
  • First Published: 11 December 2008
Free Access

338 Prevalence and prognosis of renal dysfunction in post MI patients

A. Torabi,  A.S. Rigby,  E.S. Kilpatrick,  J.G.F. Cleland, 
  • Page: 77
  • First Published: 11 December 2008
Free Access

340 Type D personality and predictors of psychological distress in heart failure patients

D.J. Frizelle,  S.L. Nabb,  M. Parekh,  J.G.F. Cleland, 
  • Page: 77
  • First Published: 11 December 2008
Free Access

341 Influence of affective status on NT-proBNP levels in patients with chronic heart failure followed in a nurse-led multidisciplinary heart failure program

N. Badosa,  J. Comin-Colet,  S. Ruiz,  M. Rizzo,  A.L. Ammirati,  B. Garcia-Bascunana,  C. Ivern,  J. Bruguera, 
  • Page: 77
  • First Published: 11 December 2008
Free Access

342 Emotional status at patient with ischemic heart disease and chronic heart failure and metabolic syndrome

A. Ibatov, 
  • Page: 78
  • First Published: 11 December 2008
Free Access

343 Depression in men with chronic heart failure: prevalence and hormone determinants

E.A. Jankowska,  B. Biel,  A. Grzeslo,  A. Drohomirecka,  T. Witkowski,  W. Banasiak,  P.A. Poole-Wilson,  P. Ponikowski, 
  • Page: 78
  • First Published: 11 December 2008
Free Access

344 Managing uncertainty in heart failure: preferences of physicians and patients regarding prognosis communication

P.H. Caldwell,  H.M. Arthur,  C. Demers, 
  • Pages: 78-79
  • First Published: 11 December 2008
Free Access

345 The effect of physiotherapy on psychological status and quality of life in patients with chronic heart failure

S. Gupta,  L. Burgess,  N. Gandhi,  C. Waywell,  T. Coppinger,  N. Brooks, 
  • Page: 79
  • First Published: 11 December 2008
Free Access

346 The incidence of anxiety and depression in patients referred with suspected heart failure

S.L. Nabb,  A.L. Clark,  K.M. Goode,  J.G.F. Cleland, 
  • Page: 79
  • First Published: 11 December 2008
Free Access

348 Heart failure in the surgical patient: awareness of principles and practice amongst health care professionals

S. Hindocha,  C. Doherty,  P.G. Wiles,  J. Heatley, 
  • Pages: 79-80
  • First Published: 11 December 2008
Free Access

349 Successful Dutch heart failure rehabilitation initiative as a result of hospital-nursing home collaboration

G.J. Van Der Putten,  A.L.M. Bakx,  G.K.M. Verhaest, 
  • Page: 80
  • First Published: 11 December 2008
Free Access

350 Optimum method for education of patients with II-IV FC CHF: Results of a two-year follow-up

G. Arutyunov,  A. Evzerikhina, 
  • Page: 80
  • First Published: 11 December 2008
Free Access

352 In-vivo forced expression of myocardin in ventricular myocardium impairs systolic performance in neonatal pig hearts

M. Torrado,  A. Centeno,  E. Lopez,  A. Castro-Beiras,  A. Mikhailov, 
  • Pages: 80-81
  • First Published: 11 December 2008
Free Access

353 Regulation of PPAR and PPAR target genes in myocardial infarction in rats

D. Fliegner,  E. Becher,  C. Schubert,  D. Westermann,  A. Riad,  C. Tschöpe,  V. Regitz-Zagrosek, 
  • Page: 81
  • First Published: 11 December 2008
Free Access

354 Trimetazidine improves post-ischemic recovery by preserving endothelial nitric oxide synthase expression in isolated working rat hearts

P. Di Napoli,  A. Grilli,  A.A. Taccardi,  M. Felaco,  A. Barsotti, 
  • Page: 81
  • First Published: 11 December 2008
Free Access

355 Plasma membrane calcium ATPase isoform 4 as a potential drug target for treatment during hypertrophy

E. Cartwright,  F. Baudoin,  D. Oceandy,  S. Prehar,  M. Zi,  L. Neyses, 
  • Page: 81
  • First Published: 11 December 2008
Free Access

356 Human embryonic stem cells improve diastolic function in rats with acute myocardial infarction

M. Lindbom,  T. Ramunddal,  E. Bollano,  E. Omerovic,  M. Sharin-Tang, 
  • Page: 82
  • First Published: 11 December 2008
Free Access

357 Comparative effects on LV performance, arterial hemodynamics and ventriculo-arterial coupling of two models of coronary artery occlusion in pigs

P.H. Kolh,  V. Tchana-Sato,  A. Ghuysen,  B. Lambermont,  S. Rolin,  V. D'orio,  R. Limet,  J.M. Dogne, 
  • Page: 82
  • First Published: 11 December 2008
Free Access

358 Effects of complete heart block on myocardial function; morphology and energy metabolism in rat model

S. Gizurarsson,  T. Ramunddal,  M. Lorentzon,  L. Bergfeldt,  F. Waagstein,  E. Omerovic, 
  • Page: 82
  • First Published: 11 December 2008
Free Access

359 Reduced angiogenic potential of sca-1 positive cardiac progenitor cells in mice with a cardiomyocyte-specific knock-out of STAT3

P.H. Fischer,  E. Missol-Kolka,  N. Zschemisch,  C. Templin,  D. Kotlarz,  H. Drexler,  D. Hilfiker, 
  • Page: 83
  • First Published: 11 December 2008
Free Access

361 Depression of cardiac working capacity in dilated cardiomyopathy

P. Alter,  H. Rupp,  B. Maisch, 
  • Page: 83
  • First Published: 11 December 2008
Free Access

362 Restoration of the force-frequency relationship by chronic cardiac resynchronization therapy is paralleled by upregulation of contractility regulating genes

W. Mullens,  J. Bartunek,  L. Delrue,  L. Herbots,  R. Willems,  M. Goethals,  S. Verstreken,  M. Vanderheyden, 
  • Pages: 83-84
  • First Published: 11 December 2008
Free Access

364 Nitric oxide mediated effects of nebivolol on cardiomyocyte apoptosis after myocardial infarction in rats

G. Mercanoglu,  H. Uzun,  F. Mercanoglu,  M. Gungor, 
  • Page: 84
  • First Published: 11 December 2008
Free Access

365 Depressed left atrial systolic function and reserve in cardiotoxic cardiomyopathy

I. Moyssakis,  M. Daskalaki,  E. Gialafos,  D. Drosos,  N. Lionakis,  V. Votteas, 
  • Page: 84
  • First Published: 11 December 2008
Free Access

366 Soluble cytokines levels and Tissue Doppler derived indexes of left ventricular systolic performance in patients with first diagnosed heart failure

C. Chrysohoou,  J. Barbetseas,  I. Kotroyiannis,  C. Pitsavos,  K. Vasiliadou,  L. Papademetriou,  N. Alexopoulos,  C. Stefanadis, 
  • Pages: 84-85
  • First Published: 11 December 2008
Free Access

368 Assessment of left ventricular systolic dysfunction by tissue Doppler imaging shows evidence of subclinical cardiomyopathy early after anthracycline therapy

M. Lotrionte,  G. Palazzoni,  R. Natali,  G. Biondi-Zoccai,  G. Comeci,  M. Savino,  B. Garramone,  F. Loperfido, 
  • Page: 85
  • First Published: 11 December 2008
Free Access

369 Patients with chronic heart failure of different classes: Changes of large intestine microflora

N.A. Bylova,  G.P. Arutyunov,  L.I. Kafarskaya,  T.K. Chernyavskaya,  Y.A. Pokrovsky,  N.A. Savelov,  A.B. Risnenko,  N.V. Kokosadze, 
  • Page: 85
  • First Published: 11 December 2008
Free Access

370 Altered intestinal barrier function, increased immune activation and IgA- endotoxin-antibodies in patients with chronic heart failure compared to controls

A. Sandek,  J. Bauditz,  S. Buhner,  W. Schroedl,  A. Swidsinski,  M. Rauchhaus,  H. Lochs,  S.D. Anker, 
  • Page: 85
  • First Published: 11 December 2008
Free Access

372 Transforming growth factor inhibition increases mortality and left ventricular dilatation after myocardial infarction

S. Frantz,  K. Hu,  A. Adamek,  J. Wolf,  A.Q. Sallam,  G. Ertl,  J. Bauersachs, 
  • Page: 86
  • First Published: 11 December 2008
Free Access

373 How can cardiac progenitor cells contribute to the presevation of heart function?

K.-D. Schluter,  S. Wenzel,  A. Muller, 
  • Page: 86
  • First Published: 11 December 2008
Free Access

374 Long-term therapy with metoprolol succinate up-regulates mRNA gene expression of glucose transporter-1 and -4 in left ventricular myocardium of dogs with chronic heart failure

S. Rastogi,  I. Alesh,  S. Goldstein,  H.N. Sabbah, 
  • Page: 86
  • First Published: 11 December 2008
Free Access

375 Does epidural spinal cord stimulation improve heart efficiency and quality of life in patients with refractory angina pectoris and chronic heart failure? Preliminary report

W. Dyrla,  M. Kuch,  M. Barczewska,  W. Maksymowicz,  L. Kostana,  M. Czubalska,  M. Dabrowski,  M. Dluzniewski, 
  • Pages: 86-87
  • First Published: 11 December 2008
Free Access

376 Right ventricular failure: electrophysiological remodeling in right ventricle precedes clinical signs

M. Hardziyenka,  M.E. Campian,  H.L. Tan, 
  • Page: 87
  • First Published: 11 December 2008
Free Access

377 Using GeneChips to screen for sex-specific targets in experimental heart failure

M. Bauer,  G. Mitterer,  W. Dietl,  K. Trescher,  W.M. Schmidt,  B.K. Podesser, 
  • Page: 87
  • First Published: 11 December 2008
Free Access

378 Acute progressively deteriorating experimental heart failure: the impact of intraaortic balloon and a non pulsatile centrifugal pump in the myocardial energetics and systemic circulation

A. Ntalianis,  S. Drakos,  C. Charitos,  K. Siafakas,  C. Pierrakos,  P. Dolou,  J. Terrovitis,  J. Nanas, 
  • Pages: 87-88
  • First Published: 11 December 2008
Free Access

379 Chronic left ventricular pacing induces regional heterogeneities in cardiac mechanical function and perfusion uncoupled with glucose uptake in minipigs

V. Lionetti,  A. Simioniuc,  L. Guiducci,  C. Simi,  A. Pingitore,  B. Scattini,  U. Startari,  F.A. Recchia, 
  • Page: 88
  • First Published: 11 December 2008
Free Access

380 Right ventricular failure: peak of myocyte death precedes clinical signs

M.E. Campian,  M. Hardziyenka,  K. De Bruin,  A.T. Soufan,  J.M. Ruijter,  M.C. Michel,  H.J. Verberne,  H.L. Tan, 
  • Page: 88
  • First Published: 11 December 2008
Free Access

381 Inhibition of beta-catenin suppresses left ventricular remodelling after infarct

L. Zelarayan,  A. Baurand,  R. Van Der Nagel,  C. Gehrke,  A. Renger,  C. Noack,  R. Dietz,  M.W. Bergmann, 
  • Page: 88
  • First Published: 11 December 2008
Free Access

402 Rac1 GTPase plays a critical role in the pathogenesis of atrial fibrillation

O. Adam,  G. Frost,  F. Custodis,  M.A. Sussman,  H.J. Schaefers,  M. Boehm,  U. Laufs, 
  • Page: 89
  • First Published: 11 December 2008
Free Access

403 A novel activator of C-C chemokine, FROUNT, is expressed with C-C chemokine receptor 2 and its ligand in failing human heart

M. Satoh,  T. Akatsu,  Y. Ishikawa,  Y. Minami,  M. Nakamura, 
  • Page: 89
  • First Published: 11 December 2008
Free Access

404 A pilot safety and dose-finding trial of intravenous recombinant human relaxin (rhRlx) in compensated congestive heart failure

T. Dschietzig,  E. Unemori,  S. Wood,  C. Richter,  S. Teichman,  K. Stangl, 
  • Page: 90
  • First Published: 11 December 2008
Free Access

405 The impact of the appetite stimulant megestrol acetate of survival, body weight and cardiac function in a rat model of chronic heart failure

J. Springer,  S. Palus,  S. Strassburg,  B. Bockmeyer,  J. Bauersachs,  C. Waller,  S.D. Anker, 
  • Page: 90
  • First Published: 11 December 2008
Free Access

406 Prognostic value of elevated circulating endothelium-derived microparticles in patients with first myocardial infarction

W. Koniarek,  M. Zielinska,  J.H. Goch, 
  • Page: 90
  • First Published: 11 December 2008
Free Access

442 Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telemonitoring

R.A. Clark,  J.J. Yallop,  L. Piterman,  J. Croucher,  A. Tonkin,  S. Stewart,  H. Krum,  on behalf of The CHAT Study Group , 
  • Page: 92
  • First Published: 11 December 2008
Free Access

443 Reaching target doses in ESC recommended treatments for chronic heart failure: still some place for improvement. Results of the IMPACT-RECO II survey

P. De Groote,  P. Assyag,  R. Isnard,  M. Galinier,  G. Jondeau,  I. Leurs,  J.F. Thebaut,  M. Komajda, 
  • Pages: 92-93
  • First Published: 11 December 2008
Free Access

444 A randomised trial of home-based exercise in patients with heart failure: results of the BRUM-CHF study

K. Jolly,  R.S. Taylor,  R. Davis,  G.Y.H. Lip,  J.W. Mant,  S. Singh,  A.J. Stevens,  M. Davies,  on behalf of The BRUM-CHF Collaborative Group , 
  • Page: 93
  • First Published: 11 December 2008
Free Access

445 Poor compliance with pharmacological treatment in chronic heart failure identifies high-risk patients and is associated with increased mortality

G.H. Gislason,  J.N. Rasmussen,  S.Z. Abildstrom,  T.K. Schramm,  S. Rasmussen,  L. Kober,  M. Madsen,  C. Torp-Pedersen, 
  • Page: 93
  • First Published: 11 December 2008
Free Access

446 Survival in patients with prevalent all-cause heart failure and borderline left ventricular systolic dysfunction

F.D.R. Hobbs,  A.K. Roalfe,  R.C. Davis,  M.K. Davies,  R. Hare, 
  • Pages: 93-94
  • First Published: 11 December 2008
Free Access

447 Remote data transmission of intracardiac pressures using home-telemonitoring in patients with heart failure

M. Schmoeckel,  F. Braunschweig,  B. Lamp,  M. Wolf,  F. Gadler,  B. Hansky,  P.H.C.M. Reiters,  M. Hill, 
  • Page: 94
  • First Published: 11 December 2008
Free Access

449 Levosimendan reduces mortality when compared with dobutamine in patients receiving beta blockers

A. Mebazaa,  A. Cohen-Solal,  F.X. Kleber,  M.S. Nieminen,  T. Sarapohja,  B. Huang,  R. Thakkar,  R.J. Padley, 
  • Page: 95
  • First Published: 11 December 2008
Free Access

450 Telemonitoring in patients with chronic heart failure - usage of telemonitoring for the outpatient care

C. Sprenger,  P. Kotsch,  M. Oeff, 
  • Pages: 95-96
  • First Published: 11 December 2008
Free Access

451 Influence of regeneration of heart muscle by intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction on Mobilization of CD34+ and CD133+ circulating progenitor cells

R.G. Turan,  M. Brehm,  M. Koestering,  T. Zeus,  T. Bartsch,  S. Steiner,  C.M. Schannwell,  B.E. Strauer, 
  • Page: 96
  • First Published: 11 December 2008
Free Access

452 Effects of a normosodic versus hyposodic diet in compensated congestive heart failure

G. Parrinello,  S. Paterna,  P. Di Pasquale, 
  • Page: 96
  • First Published: 11 December 2008
Free Access

453 Safety of spironolactone use in ambulatory HF patients

R. Lopes,  P. Lourenco,  J. Mascarenhas,  A. Azevedo,  P. Bettencourt, 
  • Pages: 96-97
  • First Published: 11 December 2008
Free Access

454 Comparison of levosimendan and dobutamine treatment in reducing N terminal pro-brain natriuretic peptide levels in patients with acutely decompensated heart failure

Y. Cavusoglu,  M. Tek,  A. Birdane,  A. Beyaztas,  C. Demirustu,  A. Unalir,  B. Gorenek,  N. Ata, 
  • Page: 97
  • First Published: 11 December 2008
Free Access

455 Combination therapy of spironolactone and candesartan increases myocardial strain associated with regression of fibrosis and reverse remodeling in chronic heart failure

M. Wang,  T. Wang,  A. Chan,  G. Yip,  W. Lam,  L. Yeung,  C.M. Yu,  J.E. Sanderson, 
  • Page: 97
  • First Published: 11 December 2008
Free Access

456 An ACEI and ARB combination in CHF outpatients: from outcome trials to clinical practice. Results from IMPACT-RECO II survey

R. Isnard,  P. Assyag,  A. Ducardonnet,  P. De Groote,  M. Galinier,  G. Jondeau,  I. Leurs,  M. Komajda, 
  • Pages: 97-98
  • First Published: 11 December 2008
Free Access

457 Vasodilatory drugs in systolic dysfunction heart failure: are we lowering blood pressure too much?

G. Mak,  C. O'Loughlin,  C. Conlon,  N. Murphy,  M. Ledwidge,  D. McCaffrey,  K. Mcdonald, 
  • Page: 98
  • First Published: 11 December 2008
Free Access

458 IV iron reduces proBNP in elderly anemic patients with heart failure and renal insufficiency

J. Toblli,  A. Lombrana,  F. Di Gennaro,  P. Duarte, 
  • Page: 98
  • First Published: 11 December 2008
Free Access

460 Recombinant human growth hormone delivered by tissue-engineered bioartificial muscle improves left ventricular function

S.L. Rong,  Y.X. Lu,  Y.H. Liao,  on behalf of Heart Failure Group , 
  • Page: 99
  • First Published: 11 December 2008
Free Access

461 COMP-angiopoietin 1 activates cytoprotective signaling pathways and inhibits hypoxia-induced apoptosis of cardiomyocytes and BM-derived mesenchymal stem cells

M.C. Cho,  J.S. Kwon,  G.Y. Koh,  E.S. Jeon,  J.J. Kim,  D.J. Choi,  K.H. Ryu,  K.K. Hwang, 
  • Page: 99
  • First Published: 11 December 2008
Free Access

462 Autologous bone marrow cell transplantation in patients with left ventricular dysfunction due to acute myocardial infarction

R. Panovsky,  J. Meluzin,  Z. Koristek,  M. Kaminek,  S. Janousek,  J. Prasek,  J. Stanicek,  L. Dusek, 
  • Page: 99
  • First Published: 11 December 2008
Free Access

464 Beta-1 adrenoceptor gene polimorphism in heart failure: clinical and prognostic significance in female patients

S. Nodari,  G. Milesi,  A. Manerba,  S. Frattini,  D. Fumagalli,  G. Seresini,  M. Metra,  L. Dei Cas, 
  • Pages: 99-100
  • First Published: 11 December 2008
Free Access

465 Beta-2 adrenergic receptors polymorphisms influence the effects of carvedilol in the patients with chronic heart failure

M. Metra,  S. Nodari,  N. Pezzali,  L. Covolo,  G. Orizio,  U. Gelatti,  F. Donato,  L. Dei Cas, 
  • Page: 100
  • First Published: 11 December 2008
Free Access

467 Elevated nestin expression in the infarcted myocardium potentially indicates differentiation of resident cardiac stem cells into various lineages including cardiomyocytes

S. Scobioala,  R. Klocke,  M. Kuhlmann,  T. Wen,  S. Koenig,  M. Eisenacher,  G. Breithardt,  S. Nikol, 
  • Pages: 100-101
  • First Published: 11 December 2008
Free Access

468 Increased MMP2 activity following treatment of cardiac fibroblast with Angiotensin II, Aldosterone, Endothelin-1 and TGF beta

C.J. Watson,  D.M.J. Phelan,  M. Ledwidge,  S. Donnelly,  K. Mcdonald,  J. Baugh,  D.M.J. Phelan, 
  • Page: 101
  • First Published: 11 December 2008
Free Access

469 Oxidative stress induces myeloperoxidase expression by HUVEC and chronic heart failure endocardial endothelial cells. Active contribution of endothelium to an inflammatory heart disease

A. Di Stefano,  G. La Rocca,  E. Eleuteri,  F. Cappello,  M. Colombo,  F. Patane,  P. Giannuzzi,  G. Zummo, 
  • Page: 101
  • First Published: 11 December 2008
Free Access

470 Transforming growth factor beta induces collagen type I and alpha smooth muscle actin production in human cardiac fibroblasts

D. Phelan,  C.J. Watson,  S. Donnelly,  M. Ledwidge,  J. Baugh,  K. Mcdonald, 
  • Page: 101
  • First Published: 11 December 2008
Free Access

471 Mechanisms underlying beta3-adrenergic eNOS-activation in human failing myocardium

A. Napp,  K. Brixius,  U. Mehlhorn,  R. Schwinger,  W. Bloch, 
  • Page: 102
  • First Published: 11 December 2008
Free Access

472 Adenosine switches macrophages from a pro-inflammatory to an angiogenic phenotype

I. Ernens,  E. Velot,  L. Valle,  M. Vausort,  D. Rouy,  Y. Devaux,  D.R. Wagner, 
  • Page: 102
  • First Published: 11 December 2008
Free Access

473 Adenosine stimulates matrix metalloproteinase-9 secretion by THP-1-derived macrophages

E. Velot,  I. Ernens,  B. Haas,  C. Jeanty,  D. Rouy,  D. Longrois,  Y. Devaux,  D.R. Wagner, 
  • Page: 102
  • First Published: 11 December 2008
Free Access

475 Effects of Levosimendan on renal function and renal hemodynamic parameters in patients with acute heart failure

C. Caira,  B. Brasolin,  V. Maestrini,  R. Scardala,  G. Orvieto,  M. Mancone,  F. Fedele, 
  • Page: 103
  • First Published: 11 December 2008
Free Access

476 Prevalence and correlation with prognostic factors of hyponatremia in patients with acute heart failure

K.H. Ryu,  M.M. Lee,  M.C. Cho,  J.J. Kim,  S.C. Chae,  E.S. Jeon,  D.J. Choi,  S.W. Han,  on behalf of Korean Acute Heart Failure Registry Group , 
  • Page: 103
  • First Published: 11 December 2008
Free Access

477 Patient self-assessments of heart failure status using either categorical or continuous scales were highly correlated in REVIVE I and II

J.R. Teerlink,  R. Thakkar,  J. Salon,  B. Huang,  R.J. Padley, 
  • Pages: 103-104
  • First Published: 11 December 2008
Free Access

478 Ularitide decreases endothelin-1 in patients with decompensated heart failure

V. Mitrovic,  P. Seferovic,  V.S. Moiseyev,  J. Moy,  J. Hiller,  I. Caras,  W.G. Forssmann,  H. Luss,  M. Meyer, 
  • Page: 104
  • First Published: 11 December 2008
Free Access

479 Transplantability and bridge to heart transplant (HTx) using intra-aortic balloon pumping (IABP) in high-urgency candidates with pulmonary hypertension

H. Guelmez,  G.T. Tenderich,  A.Z. Zittermann,  U.S. Schulz,  R.S. Koerfer, 
  • Page: 104
  • First Published: 11 December 2008
Free Access

480 Minimally invasive bridge to transplant with Intra-Aortic Balloon Pumping (IABP) in high-urgency candidates for Heart Transplants (HTx)

H. Guelmez,  G.T. Tenderich,  A.Z. Zittermann,  U.S. Schulz,  R. Koerfer, 
  • Page: 104
  • First Published: 11 December 2008
Free Access

481 Characteristics and hospital outcomes of patients with heart failure complicating acute coronary syndromes

Z. Vasiljevic,  D. Matic,  N. Mickovska,  D. Babic,  Z. Brankovic,  N. Trifunovic,  N. Macura,  M. Zrnic,  on behalf of RACSS investigators , 
  • Page: 105
  • First Published: 11 December 2008
Free Access

482 The pathogenesis of hypertensive acute pulmonary edema

I.A. Vogiatzis,  V. Sachpekidis,  I.M. Vogiatzis,  E. Kambitsi,  V. Tsagaris,  M. Konstantinidou,  D. Mournos, 
  • Page: 105
  • First Published: 11 December 2008
Free Access

483 The long-term prognostic role of routine cardiac troponin T measurement in acute heart failure syndromes. A multicentre international retrospective collaboration

N. Aspromonte,  E.R. Perna,  G. Di Tano,  J.P. Cimbaro Canella,  S.M. Macin,  M.L. Coronel,  L. Milani,  R. Valle, 
  • Pages: 105-106
  • First Published: 11 December 2008
Free Access

484 Diversity of clinical manifestations of patients with acute heart failure

K.H. Ryu,  M.M. Lee,  S.C. Chae,  M.C. Cho,  E.S. Jeon,  D.J. Choi,  J.J. Kim,  J.W. Ha,  on behalf of Korean Acute Heart Failure Registry , 
  • Page: 106
  • First Published: 11 December 2008
Free Access

485 Characteristics and hospital outcomes of patients with heart failure complicating acute coronary syndromes

Z. Vasiljevic,  D. Matic,  N. Mickovska,  D. Babic,  Z. Brankovic,  N. Trifunovic,  N. Macura,  M. Zrnic,  on behalf of RACSS investigators , 
  • Page: 106
  • First Published: 11 December 2008
Free Access

486 Clinical composite endpoint classification of REVIVE II corresponds to all-cause mortality risk

J.R. Teerlink,  L. Delgado-Herrera,  R. Thakkar,  B. Huang,  R.J. Padley, 
  • Pages: 106-107
  • First Published: 11 December 2008
Free Access

487 Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock

E. Omerovic,  T. Ramunddal,  P. Albertsson,  G. Matejka, 
  • Page: 107
  • First Published: 11 December 2008
Free Access

488 In hospital mortality after admission for acute heart failure is two fold higher in patients older than 80 years. Insights from the Italian AHF registry

D. Miani,  C. Fresco,  D. Lucci,  M.C. Albanese,  L. Mainardi,  G. Musmeci,  A.P. Maggioni,  L. Tavazzi,  Italian Survey on Acute Heart Failure Investigators , 
  • Page: 107
  • First Published: 11 December 2008
Free Access

489 Prognostic variables in patients hospitalised for acute heart failure: a single center experience

M. Metra,  S. Nodari,  G. Verzura,  B. Fontanella,  S. Bugatti,  T. Bordonali,  P. Milani,  L. Dei Cas, 
  • Pages: 107-108
  • First Published: 11 December 2008
Free Access

490 Can we predict Killip class worsening in acute coronary syndrome patients?

S. Monteiro,  P. Monteiro,  S. Costa,  F. Goncalves,  L. Goncalves,  M. Freitas,  L. Providencia, 
  • Page: 108
  • First Published: 11 December 2008
Free Access

491 Systolic blood pressure at admission and outcomes in patients hospitalized with acute heart failure

S. Verde,  M. Mariani,  E. Pizzolato,  A. Spotti,  S. Pirelli,  R. De Maria, 
  • Page: 108
  • First Published: 11 December 2008
Free Access

492 BNP and bioelectrical impedance analysis-guided treatment for predicting outcome in patients hospitalised with acute heart failure

N. Aspromonte,  M. Chiatto,  P. Giovinazzo,  S. Barro,  F. Noventa,  S. Bardellotto,  L. Milani,  R. Valle, 
  • Pages: 108-109
  • First Published: 11 December 2008
Free Access

493 Increased expression of Fractalkine (CX3CL1) in endomyocardial biopsies from patients presenting with acute myocarditis

M. Noutsias,  M. Rohde,  A. Block,  K. Blunert,  M. Hummel,  D. Lassner,  U. Kuehl,  H.D. Volk, 
  • Page: 109
  • First Published: 11 December 2008
Free Access

494 Levosimendan, compared to dobutamine, reduces mortality in patients with a history of heart failure

A. Cohen-Solal,  A. Mebazaa,  R. Thakkar,  G. Schulz,  B. Huang,  R.J. Padley, 
  • Page: 109
  • First Published: 11 December 2008
Free Access

495 Hospitalization for exacerbation chronic heart failure may be predicted

M. Shochat,  M. Kazatzker,  P. Rabinovich,  D. Blondhaim,  A. Shotan,  S. Meisel, 
  • Page: 109
  • First Published: 11 December 2008
Free Access

496 Clinical profile and long-term prognosis of women hospitalized because of acute heart failure

B. Redondo,  D.A. Pascual Figal,  P. Penafiel,  J.A. Hurtado,  I.P. Garrido,  J.A. Giner,  F. Pastor,  M. Valdes, 
  • Page: 110
  • First Published: 11 December 2008
Free Access

497 NHS Heart Failure Survey - Acute heart failure admissions in England, Wales and Northern Ireland - demographics, clinical presentation and pre-admission pharmacology

E.D. Nicol,  B. Fittal,  M. Roughton,  H. Dargie,  J.G.F. Cleland,  M. Cowie,  on behalf of Healthcare Commission and British Society for Heart Failure , 
  • Page: 110
  • First Published: 11 December 2008
Free Access

498 Prognostic value of Troponin I and T in acute decompensated heart failure

T.J. Ilva,  J.P.E. Lassus,  V.-P. Harjola,  K. Siirila-Waris,  K. Peuhkurinen,  K. Pulkki,  P. Porela,  M.S. Nieminen,  on behalf of FINN-AKVA study group , 
  • Page: 110
  • First Published: 11 December 2008
Free Access

499 Influence of selective beta-blocker of ultra short action esmolol on parameters of the central haemodynamics in patients with acute myocardial infarction complicated by a heart failure

I. Kositsina,  A. Golubev,  S. Tereschenko, 
  • Page: 111
  • First Published: 11 December 2008
Free Access

500 Effects of the selective A1 adenosine receptor antagonist KW-3902 in the treatment of patients with acute heart failure, congestion and renal impairment: rationale and design of the study

C. O'Connor,  H.C. Dittrich,  M. Metra,  B.D. Weatherley,  B.M. Massie,  on behalf of PROTECT Investigators , 
  • Page: 111
  • First Published: 11 December 2008
Free Access

501 Comparing the sensitivity of non-invasive markers of volume response to intravenous furosemide in patients with acute pulmonary oedema

M.J. Ng Kam Chuen,  G.Y.H. Lip,  R.J. Macfadyen, 
  • Pages: 111-112
  • First Published: 11 December 2008
Free Access

502 Hyperuricemia in acute heart failure: more than a simple spectator?

J. Nunez,  L. Consuegra,  G. Minana,  R. Robles,  J. Sanchis,  V. Bodi,  E. Nunez,  A. Llacer, 
  • Page: 112
  • First Published: 11 December 2008
Free Access

503 Time course of the haemodynamic effects of levosimendan in heart failure patients: an echocardiographic study

C. Caira,  B. Brasolin,  V. Maestrini,  R. Scardala,  G. Orvieto,  L.M. Zuccaro,  M. Mancone,  F. Fedele, 
  • Page: 112
  • First Published: 11 December 2008
Free Access

505 Heart failure as a significant predictor of supraventricular arrhythmia in adult patients with congenital heart diseases

O. Trojnarska,  S. Grajek,  L. Kramer,  M. Lanocha,  A. Katarzyska, 
  • Pages: 112-113
  • First Published: 11 December 2008
Free Access

506 Systolic and diastolic function of left ventricle evaluated by tissue Doppler imaging in adult patients after total correction of coarctation of aorta

O. Trojnarska,  M. Lanocha,  Z. Oko-Sarnowska,  A. Szyszka, 
  • Page: 113
  • First Published: 11 December 2008
Free Access

508 Wireless pulmonary pressure monitoring in patient with heart failure

R. Concepcion,  P. Castro,  H. Verdejo,  M. Alcaino,  A. Martinez,  M. Alfaro,  M. Ferrada,  S.V. Perrone, 
  • Page: 113
  • First Published: 11 December 2008
Free Access

509 Therapy with Vagus nerve electrical stimulation combined with beta-blockade improves left ventricular systolic function in dogs with heart failure beyond that seen with beta-blockade alone

H.N. Sabbah,  M. Imai,  A. Zaretsky,  S. Rastogi,  M. Wang,  A. Jiang,  V. Zaca, 
  • Page: 114
  • First Published: 11 December 2008
Free Access

510 Treatment of end-stage heart failure with the DuraHeart mag-lev centrifugal left ventricular assist system

A. El-Banayosy,  L. Arusoglu,  M. Morshuis,  L. Kizner,  D. Roefe,  D. Cobaugh,  R. Koerfer, 
  • Page: 114
  • First Published: 11 December 2008
Free Access

511 Examining the outcomes of long-term ventricular assist device (VAD) support with a range of devices - an eight year single centre experience

C. Wood,  L. Dembo,  R. Larbalestier,  G. O'Driscoll, 
  • Page: 114
  • First Published: 11 December 2008
Free Access

512 Feasibility of a new device-based approach for treating diastolic heart failure

S. Dubi,  Y. Feld,  R. Shofti,  A. Pinhasi,  E. Schwammenthal,  A. Elami, 
  • Page: 115
  • First Published: 11 December 2008
Free Access

513 The surgical approach to reverse ventricular remodelling with the use of ventricular assist devices as bridge to recovery

A.A. Pitsis,  A.N. Visouli,  V. Ninios,  D. Deliaslani,  V. Vassilikos,  G.S. Filippatos, 
  • Page: 115
  • First Published: 11 December 2008
Free Access

514 Mechanical circulatory assistance as a bridge to transplantation

A. Gkouziouta,  S. Adamopoulos,  G. Karavolias,  A. Manginas,  T. Antoniou,  L. Tsourelis,  P.A. Alivizatos,  P. Sfirakis, 
  • Page: 115
  • First Published: 11 December 2008
Free Access

515 Acquired von Willebrand syndrome in patients with left heart assist device

D. Malehsa,  C. Bara,  A. Meyer,  C. Kuehn,  A. Haverich,  M. Strueber, 
  • Pages: 115-116
  • First Published: 11 December 2008
Free Access

517 Aspirin resistance in patients with stable angina and chronic heart failure

Y. Grinshtein,  E. Savchenko,  I. Grinshtein,  A. Savchenko, 
  • Page: 116
  • First Published: 11 December 2008
Free Access

518 Implementation of ESC guidelines in clinical practice: results of the French IMPACT-RECO II survey

M. Komajda,  P. Assyag,  P. De Groote,  A. Ducardonnet,  R. Isnard,  M. Galinier,  I. Leurs,  G. Jondeau,  on behalf of IMPACT-RECO group , 
  • Page: 116
  • First Published: 11 December 2008
Free Access

519 Long-term administration of Nebivolol does not cause nitrate tolerance

G. Stoschitzky,  P. Lercher,  R. Maier,  N. Watzinger,  F.M. Fruhwald,  R. Zweiker,  H. Brussee,  K. Stoschitzky, 
  • Pages: 116-117
  • First Published: 11 December 2008
Free Access

520 Prescribing patterns for evidence-based drug therapy in patients with chronic heart failure: are target doses and multiple medication therapies realistic?

A. Driscoll,  L. Worrall Carter,  D.L. Hare,  P.M. Davidson,  B. Riegel,  A. Tonkin,  S. Stewart, 
  • Page: 117
  • First Published: 11 December 2008
Free Access

521 Factors related to the ARB prescription in patients with heart failure. Results of the IMPACT-RECO II survey

M. Galinier,  P. Assyag,  P. De Groote,  R. Isnard,  G. Jondeau,  I. Leurs,  J.F. Thebaut,  M. Komajda, 
  • Page: 117
  • First Published: 11 December 2008
Free Access

522 Prescription in patients with systolic heart failure: glance to beta blockers

M.B. Yilmaz,  M. Refiker,  Y. Guray,  U. Guray,  H. Altay,  B. Demirkan,  V. Caldir,  S. Korkmaz, 
  • Pages: 117-118
  • First Published: 11 December 2008
Free Access

523 Preoperative coronary surgery utilization of levosimendan in patients with severe left ventricular function

R. Porcile,  G.P.B. Perez Baztarrica,  R.L.L. Levin,  F.A.S. Salvaggio,  G.B. Ballarino,  J.L. Schnidt,  N. Blanco,  L.A. Botbol, 
  • Page: 118
  • First Published: 11 December 2008
Free Access

524 Effects of levosimendan and dobutamine on levels of N-terminal pro-brain natriuretic peptide in decompensated heart failure

A. Gurlek,  C. Tulunay Kaya,  S. Turhan,  C. Erol, 
  • Page: 118
  • First Published: 11 December 2008
Free Access

525 Out of hospital treatment with intravenous diuretics in patients with refractory heart failure

A.H.M. Veelenturf,  R. Zwart,  P. Meregalli,  M. Pfeiffer,  W. Kok, 
  • Pages: 118-119
  • First Published: 11 December 2008
Free Access

526 Use of beta blockers in HF patients with chronic obstructive pulmonary disease

P. Lourenco,  J. Mascarenhas,  R. Lopes,  A. Azevedo,  P. Bettencourt, 
  • Page: 119
  • First Published: 11 December 2008
Free Access

527 Long-term spironolactone treatment improves daytime HRV indices in CHF patients, already receiving optimal therapy

A. Skvortsov,  V. Mareev,  J. Orlova,  S. Chelmakina,  N. Baklanova,  Y. Belenkov, 
  • Page: 119
  • First Published: 11 December 2008
Free Access

528 Acute neurohormonal response can identify responding patients after levosimendan treatment

G. Giannakoulas,  G. Giannoglou,  V. Vassilikos,  P. Kalpidis,  K. Martiadou,  G. Parharidis,  G. Louridas, 
  • Pages: 119-120
  • First Published: 11 December 2008
Free Access

529 Levosimendan versus dobutamine in patients with moderate to severe right ventricular dysfunction on top of severe left ventricular failure

M.B. Yilmaz,  C. Yontar,  A. Erdem,  F. Karadas,  K. Yalta,  O.O. Turgut,  A. Yilmaz,  I. Tandogan, 
  • Page: 120
  • First Published: 11 December 2008
Free Access

530 Discrepancies in pharmacological management between women and men with congestive heart failure in primary care settings registry

R. Glowczynska,  A. Pietrasik,  M.E. Starczewska,  K.J. Filipiak,  G. Opolski,  on behalf of POLKARD-SPOK , 
  • Page: 120
  • First Published: 11 December 2008
Free Access

531 Beta-blockers in octagenarians with chronic heart failure: just do it

G. Borelli,  A. Barison,  M. Coceani,  D. Barone,  F. Castrogiovanni,  L. Rondinini,  R. Mariotti, 
  • Pages: 120-121
  • First Published: 11 December 2008
Free Access

532 Atorvastatin exerts global anti-inflammatory and antithrombotic effects in patients with congestive heart failure

C. Antoniades,  D. Tousoulis,  K. Marinou,  E. Basinakou,  E. Stefanadi,  C. Tentolouris,  G. Siasos,  C. Stefanadis, 
  • Page: 121
  • First Published: 11 December 2008
Free Access

533 Optimization of heart failure drug therapy: symptoms or NT-proBNP guided?

P. Morais Sarmento,  C. Fonseca,  S. Leal,  I. Araujo,  D. Sanz,  A. Minez,  J. Esperanca-Pina,  F. Ceia, 
  • Page: 121
  • First Published: 11 December 2008
Free Access

534 Discontinuation of heart failure medical therapy in a disease management programme predicts poorer outcome and increased costs

M. Mockler,  C. O'Loughlin,  C. Conlon,  K. Mcdonald,  M. Ledwidge, 
  • Pages: 121-122
  • First Published: 11 December 2008
Free Access

535 Improvement in mechanical alternans as shown by Doppler in patients with severe heart failure: levosimendan versus dobutamine

M.B. Yilmaz,  F. Karadas,  A. Erdem,  I. Tandogan, 
  • Page: 122
  • First Published: 11 December 2008
Free Access

536 Different beta-blocking effects of metoprolol, bisoprolol and carvedilol

G. Stoschitzky,  R. Maier,  P. Lercher,  H. Brussee,  R. Zweiker,  N. Watzinger,  F.M. Fruhwald,  K. Stoschitzky, 
  • Page: 122
  • First Published: 11 December 2008
Free Access

537 The effect of levosimendan on left ventricular systolic and diastolic function and systolic pulmonary artery pressure in patients taking carvedilol

H. Duygu,  M. Zoghi,  S. Nalbantgil,  F. Ozerkan,  U. Erturk,  R. Onder,  A. Akilli,  M. Akin, 
  • Pages: 122-123
  • First Published: 11 December 2008
Free Access

538 Influence of metformin on the parameters of oxidative stress in patients with combined heart failure and diabetes mellitus

N. Arzamastseva,  Y. Lapina,  F. Ageev,  V. Lankin,  V. Mareev,  Y. Belenkov, 
  • Page: 123
  • First Published: 11 December 2008
Free Access

539 Triple combination may provoke hypotension which is associated with RAAS and SAS reactivation in CHF patients

A. Skvortsov,  V. Mareev,  S. Nasonova,  G. Arbolishvili,  G. Litonova,  N. Baklanova,  Y. Belenkov, 
  • Page: 123
  • First Published: 11 December 2008
Free Access

540 Effects of atorvastatin on serum markers of inflammation, arterial wall properties and haemodynamic parameters in patients with ischaemic heart failure

E.M. Ozova,  Z.H.D. Kobalava,  V.S. Moiseev,  G.K. Kiyakbaev, 
  • Pages: 123-124
  • First Published: 11 December 2008
Free Access

541 Do statins and antithrombotics reduce mortality in patients with heart failure in daily practice: a study in primary care

F.H. Rutten,  M.-J.M. Cramer,  A.W. Hoes,  on behalf of Utrecht Heart Failure Organisation (UHFO) , 
  • Page: 124
  • First Published: 11 December 2008
Free Access

542 Pentoxifylline improves the haemoglobin levels in anaemic patients with chronic heart failure

M. Lainscak,  S.D. Anker,  S. Von Haehling,  P. Ponikowski,  K. Sliwa, 
  • Page: 124
  • First Published: 11 December 2008
Free Access

543 Effects of nebivolol versus carvedilol in hypertensive patients with chronic heart failure

G. Marazzi,  M. Volterrani,  G. Caminiti,  R. Massaro,  A. Carluccio,  L. Gatta,  G. Rosano, 
  • Pages: 124-125
  • First Published: 11 December 2008
Free Access

545 Prevalence of echocardiographic abnormalities in metabolic syndrome: a population based study

B. Aijaz,  K.A. Ammar,  M.M. Redfield,  S.J. Jacobson,  R.J. Rodeheffer, 
  • Page: 125
  • First Published: 11 December 2008
Free Access

546 Tissue Doppler imaging: a non-invasive technique for estimation of NT pro-BNP levels in patients with left ventricular dysfunction

C. Mornos,  A. Ionac,  D. Cozma,  D. Dragulescu,  A. Bokor,  C. Sarau,  A. Lupu,  S.I. Dragulescu, 
  • Page: 125
  • First Published: 11 December 2008
Free Access

547 Echocardiographic characteristics including tissue Doppler imaging after enhanced external counterpulsation therapy

G. Estahbanaty,  N. Samiei,  M. Maleki,  F. Noohi,  A. Mohebi,  Z. Ojaghi,  M. Esmaeilzadeh,  O. Soran, 
  • Pages: 125-126
  • First Published: 11 December 2008
Free Access

548 Ventricular dyssynchrony measured using standard echocardiography or tissue Doppler imaging: do the results agree?

A. Navazio,  L. Tarantini,  N. Muia,  M. Iori,  M. Calzolari,  E. Lo Jacono,  O. Gaddi,  U. Guiducci, 
  • Page: 126
  • First Published: 11 December 2008
Free Access

549 Left ventricular mechanical dyssynchrony assessed with 3D real time echocardiography and ejection fraction in patients with previous myocardial infarction, dilated cardiomyopathy and controls

E. De Marco,  S. De Vecchi,  V. Magnano,  F. Forni,  D. Pappalardo,  F. Platini,  F. Rametta, 
  • Page: 126
  • First Published: 11 December 2008
Free Access

550 Global and regional myocardial function quantification by two-dimensional strain (2D-Strain) in patients with restrictive cardiomyopathy caused by cardiac amyloidosis

T. Butz,  L. Faber,  S. Jategaonkar,  C. Langer,  B. Lamp,  C. Piper,  D. Horstkotte, 
  • Page: 126
  • First Published: 11 December 2008
Free Access

551 Wave intensity assessment of arterial-ventricular coupling parameters predicts haemodynamic deterioration in patients with end-stage dilated cardiomyopathy

H. Siniawski,  H.B. Lehmkuhl,  A. Unbehaun,  M. Jurmann,  M. Dandel,  Y. Weng,  R. Hetzer, 
  • Page: 127
  • First Published: 11 December 2008
Free Access

552 Right ventricular involvement and its prognostic value for heart failure development in patients with isolated extreme obesity

K. Branidou,  C.M. Stanescu,  C. Baicus,  R. Vasilescu,  G.A. Dan, 
  • Page: 127
  • First Published: 11 December 2008
Free Access

553 Levosimendan improves diastolic function and reduces the degree of functional mitral regurgitation in patients with moderate heart failure

G. Branzi,  G. Malfatto,  F. Ciambellotti,  M. Revera,  M. Facchini,  G. Parati, 
  • Page: 127
  • First Published: 11 December 2008
Free Access

554 Comparison of left ventricular tangential and radial movement in patients with chronic heart failure using vector velocity imaging echocardiography

Y. Sun,  W. Ruan,  Y.Q. Xu,  W.F. Shen, 
  • Page: 128
  • First Published: 11 December 2008
Free Access

555 Assessment the value of left atrial volume as a relatively independent echocardiographic marker of diastolic function in patients with end-stage renal disease during hemodialysis

D. Mytas,  P. Stougiannos,  M. Zairis,  I. Kyriazis,  L. Kosma,  C. Baltas,  S. Foussas,  V. Pyrgakis, 
  • Page: 128
  • First Published: 11 December 2008
Free Access

556 Coronary artery bypass surgery versus medical treatment in patients with a low ejection fraction and coronary artery disease: a dobutamine stress echocardiography study

H. Sadeghian,  A.L. Karimi,  H. Ahmadi,  S. Sadeghian,  M. Salarifar,  M. Lotfi-Tokaldany,  H. Abbasi,  M. Shekh Phatollahi, 
  • Page: 128
  • First Published: 11 December 2008
Free Access

557 Echocardiographic assessments of left atrial function and filling pressure correlate with exercise capacity in patients with chronic congestive heart failure

E. Donal,  C. Deplace,  R. Gervais,  P. Raud-Raynier,  F. Carre,  J.C. Daubert,  P. Mabo,  C. Leclercq, 
  • Pages: 128-129
  • First Published: 11 December 2008
Free Access

558 Relation between left ventricle diastolic function changes during stress echocardiography and exercise capacity in ischemic heart failure patients

P. Rubis,  P. Podolec,  L. Tomkiewicz-Pajak,  G. Kopec,  W. Tracz, 
  • Page: 129
  • First Published: 11 December 2008
Free Access

559 Comparison of benefits of cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy

N. Antonio,  L. Coelho,  P. Monteiro,  R. Martins,  M. Ventura,  L. Elvas,  L. Goncalves,  L.A. Providencia, 
  • Page: 129
  • First Published: 11 December 2008
Free Access

561 Persisting anaemia one year after heart transplantation is not associated with an adverse long-term prognosis

S. Arora,  A.K. Andreassen,  E. Gude,  S. Simonsen,  R. Skaardal,  A. Fiane,  O. Geiran,  L. Gullestad, 
  • Page: 130
  • First Published: 11 December 2008
Free Access

562 Levosimendan for acute decompensated end-stage chronic heart failure: experience in a heart transplant programme

V. Suberviola Sanchez,  M.J. Ruiz Cano,  J.F. Delgado Jimenez,  P. Escribano Subias,  V. Sanchez Sanchez,  A. Flox Camacho,  R. Alonso Gonzalez,  C. Saenz De La Calzada, 
  • Page: 130
  • First Published: 11 December 2008
Free Access

563 Usefulness of N-terminal-pro-brain natriuretic peptide and C-reactive protein levels in following heart transplant recipients

C.M. Tavares Aguiar,  M.J. Rebocho,  M. Abecasis,  M. Marques,  R. Hernandez,  J. Figueira,  R. Gouveia,  J. Melo, 
  • Page: 130
  • First Published: 11 December 2008
Free Access

564 Patients affected by heart failure with peak oxygen consumption between 10-18 ml/kg/min: cardiopulmonary test offers additional parameters for a better prognostic stratification?

A. Di Lenarda,  M. Merlo,  D. Clama,  E. Berton,  S. Pyxaras,  G. Secoli,  M. Moretti,  G. Sinagra, 
  • Page: 131
  • First Published: 11 December 2008
Free Access

565 Prognostic role of cardiopulmonary exercise indexes in patients with heart failure receiving beta-blockers

A. Di Lenarda,  D. Clama,  M. Merlo,  E. Berton,  D. Gregori,  S. Rakar,  S. Pyxaras,  G. Sinagra,  on behalf of Trieste Heart Muscle Disease Registry , 
  • Page: 131
  • First Published: 11 December 2008
Free Access

566 C2 monitoring of cyclosporine in heart transplant patients offers no clinical benefit over C0 monitoring - Zurich single center experience

M. Hermann,  A. Weber,  F. Ruschitzka,  G. Noll, 
  • Page: 131
  • First Published: 11 December 2008
Free Access

567 Should UNOS status 2 patients undergo transplantation?

H. Duygu,  M. Zoghi,  S. Nalbantgil,  S. Akyuz,  M. Akin,  T. Yagdi,  M. Ozbaran, 
  • Page: 132
  • First Published: 11 December 2008
Free Access

568 Redo cardiac surgery: is there an impact on heart transplantation outcome? A single centre experience

G. Guzzi,  E. Spagna,  V. Tursi,  M.C. Albanese,  D. Miani,  E. Mazzaro,  E. Auci,  U. Livi, 
  • Page: 132
  • First Published: 11 December 2008
Free Access

569 Sirolimus and mycophenolate mofetil as new possibility of immunosuppression for late heart transplant patients with chronic renal dysfunction

P. Hude,  L. Spinarova,  J. Krejci,  H. Pavelcikova,  J. Cerny,  A. Sirotkova, 
  • Page: 132
  • First Published: 11 December 2008
Free Access

571 Novel compliance index derived from digital volume pulse associated with risk factors and exercise capacity in patients undergoing treadmill exercise tests

W.-C. Tsai,  J.-Y. Chen,  C.-C. Lin,  M.-S. Wu,  J.-H. Chen, 
  • Pages: 132-133
  • First Published: 11 December 2008
Free Access

572 Correlation of delayed enhancement and no reflow area measured by cardiac MRI and N-terminal-B-type natriuretic peptide in patients with first acute ST segment elevation myocardial infarction

C. Jensen,  M. Farazandeh,  M. Jochims,  P. Hunold,  G.V. Sabin,  O. Bruder,  J. Barkhausen, 
  • Page: 133
  • First Published: 11 December 2008
Free Access

573 Patient and provider satisfaction with real-time echocardiography and cardiac consultation performed at a distance using broadband technology

M. Olofsson,  K. Boman, 
  • Page: 133
  • First Published: 11 December 2008
Free Access

574 Cardiac sympathetic denervation detected by enhanced 123I-metaiodobenzylguanidine (MIBG) washout in heart failure patients with impaired autonomic function

A.S. Coimbra,  S.M. Miranda,  R.R.T. Castro,  M. Magalhaes,  J.C. Azevedo,  P. Lavatori,  A.C.L. Nobrega,  C. Tinoco, 
  • Page: 134
  • First Published: 11 December 2008
Free Access

575 Utility of combining ultrasonographic parameters of carotid atherosclerosis and creatinine plasma levels, for predicting significant coronary artery disease

N. Cicorella,  L. Zanolla,  L. Franceschini,  A. Rossi,  B. De Cristan,  M. Arieti,  G. Cacici,  C. Vassanelli, 
  • Page: 134
  • First Published: 11 December 2008
Free Access

577 The prognostic value of atherosclerotic renal artery stenosis and kidney size in patients with left ventricular systolic dysfunction

P.H. Loh,  C.V. Bourantas,  D.P. Ettles,  R. De Silva,  E. Lukaschuk,  A.L. Clark,  N.P. Nikitin,  J.G.F. Cleland, 
  • Pages: 134-135
  • First Published: 11 December 2008
Free Access

578 Delayed enhancement magnetic resonance imaging utility to predict response to cardiac resynchronization therapy

A. Valle,  M. Nadal,  J. Estornell,  V. Jacas,  A. Trigo,  A. Quesada,  R. Paya,  F. Ridocci, 
  • Page: 135
  • First Published: 11 December 2008
Free Access

579 Correlation between exercise variables and gated perfusion spect data in heart failure patients: a nuclear ancillary study from the HF-ACTION trial

G.L. Adams,  D.J. Whellan,  C.M. O'Connor,  D.R. Bensimhon,  D. Rendall,  R.A. Pagnanelli,  S. Borges-Neto,  on behalf of HF-ACTION , 
  • Page: 135
  • First Published: 11 December 2008
Free Access

581 Myocardial scar and insulin resistance predict cardiovascular events in severe ischemic myocardial dysfunction. A Perfusion/Metabolism Positron Emission Tomography study

M. Feola,  G. Leonardi,  S. Peano,  S. Chauvie,  G.L. Rosso,  F. Rolfo,  A. Bianchi,  A. Biggi, 
  • Pages: 135-136
  • First Published: 11 December 2008
Free Access

583 Decreased nitric oxide production after cardioplegia-induced cardiac arrest under cardiopulmonary bypass induced cardiomyocytic apoptosis by activation of the unfolded protein response

C.H. Yeh,  Y.M. Lin,  P.J. Lin, 
  • Page: 136
  • First Published: 11 December 2008
Free Access

584 Functional improvement after mitral surgery in patients undergoing radiofrequency ablation of AF is related to long-term maintenance of SR

S. Caciolli,  C. Rostagno,  F. Fradella,  G.F. Montesi,  S. Bevilacqua,  P.L. Stefano, 
  • Page: 136
  • First Published: 11 December 2008
Free Access

586 Right ventricular tissue Doppler imaging as a prognostic marker in advanced heart failure

D. Farmakis,  J.T. Parissis,  V. Bistola,  I. Paraskevaidis,  F. Panou,  E. Iliodromitis,  G. Filippatos,  D. Kremastinos, 
  • Page: 137
  • First Published: 11 December 2008
Free Access

587 Levosimendan does not induce ischemia in patients with ischemic heart failure: a new evidence from ultrasonic tissue characterization with integrated backscatter analysis

H. Duygu,  S. Nalbantgil,  M. Zoghi,  F. Ozerkan,  M. Akin, 
  • Page: 137
  • First Published: 11 December 2008
Free Access

649 Clinical and hemodynamic effects of bosentan in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension – A randomized multi-center study

E. Kaluski,  M. Leitman,  G. Cotter,  O. Milo-Cotter,  I. Kobrin,  A. Caspi,  T. Moriconi,  Z. Vered, 
  • Page: 138
  • First Published: 11 December 2008
Free Access

650 Effects of levosimendan on quality of life and emotional stress in patients with advanced heart failure

K. Papadopoulos,  J.T. Parissis,  M. Nikolaou,  V. Bistola,  D. Farmakis,  V. Gogas,  G. Filippatos,  D. Kremastinos, 
  • Page: 138
  • First Published: 11 December 2008
Free Access

651 Losartan improved insulin resistance and decreased TNF-alpha in patients with chronic heart failure

K. Ogino,  M. Kato,  Y. Furuse,  Y. Kinugasa,  K. Ishida,  O. Igawa,  I. Hisatome,  C. Shigemasa, 
  • Page: 139
  • First Published: 11 December 2008
Free Access

652 Is heart rate lowering per se beneficial in chronic heart failure management and permanent cardiac pacing?

D. Logeart,  V. Ciobotaru,  J.P. Gueffet,  F. Pousset,  F. Rouzet,  G. Jondeau, 
  • Page: 139
  • First Published: 11 December 2008
Free Access

653 Frusemide and mortality in a rat model of chronic heart failure

J. Springer,  S. Strassburg,  S. Palus,  B. Bockmeyer,  Y. Akashi,  C. Waller,  J. Bauersachs,  S.D. Anker, 
  • Page: 139
  • First Published: 11 December 2008
Free Access

654 Long-acting testosterone improves exercise oxygen uptake, insulin resistance and muscle strength in elderly patients with chronic heart failure

G. Caminiti,  M. Volterrani,  R. Massaro,  G. Marazzi,  B. Sposato,  L. Gatta,  G. Rosano, 
  • Pages: 139-140
  • First Published: 11 December 2008
Free Access

656 Titin mutation in familial idiopathic dilated cardiomyopathy from the Galilee

D. Freimark,  G. Yoskovitz,  M. Gramlich,  L. Thierfelder,  M.S. Feinberg,  E. Pras,  M. Arad,  B. Gerull, 
  • Page: 141
  • First Published: 11 December 2008
Free Access

657 Dual S100A1/BARKct adenoviral gene transfer in ventricular cardiomyocytes

C. Weidenhammer,  M. Voelkers,  N. Herzog,  S.T. Pleger,  H.A. Katus,  W.J. Koch,  P. Most, 
  • Page: 141
  • First Published: 11 December 2008
Free Access

658 Overexpression of apolipoprotein-B improves cardiac function and increases survival in mice

T. Ramunddal,  M. Lindbom,  M. Scharin-Tang,  J. Boren,  E. Omerovic, 
  • Page: 142
  • First Published: 11 December 2008
Free Access

659 Angiotensin-converting enzyme 2 (ACE2) gene polymorphisms and long-term survival in advanced heart failure

P. Leszek,  A. Ciechanowicz,  M. Szperl,  W. Piotrowski,  A. Browarek,  M. Zembala,  P. Przybylowski,  J. Korewicki, 
  • Page: 142
  • First Published: 11 December 2008
Free Access

660 Deficiency of Toll-like receptor 4 leads to cardioprotection against doxorubicin-induced cardiomyopathy

A. Riad,  S. Bien,  M. Gratz,  S. Bereswill,  H.P. Schultheiss,  H.K. Kroemer,  C. Tschöpe, 
  • Pages: 142-143
  • First Published: 11 December 2008
Free Access

662 Darbepoetin-alfa reduces plasma interleukin-6 and C-reactive protein and improves quality of life in patients with chronic heart failure and anemia

K. Kourea,  J.T. Parissis,  F. Panou,  D. Farmakis,  K. Venetsanou,  G. Filippatos,  D. Kremastinos, 
  • Page: 143
  • First Published: 11 December 2008
Free Access

663 Effect of adrenomedulin on myocardial distensibility

A.P. Fontes-Sousa,  A.L. Pires,  A.F. Leite-Moreira, 
  • Page: 143
  • First Published: 11 December 2008
Free Access

664 Circulating levels of tumor necrosis factor-alpha, brain natriuretic peptide and cardiac troponin I upon admission and 31-day mortality in patients with acute decompensated chronic heart failure

D. Mytas,  M. Zairis,  S. Makrygiannis,  P. Batika-Zairi,  K. Kontos,  N. Patsourakos,  E. Adamopoulou,  S. Foussas, 
  • Page: 143
  • First Published: 11 December 2008
Free Access

665 Anti-depressive medication decreases tumor necrosis factor alpha and C-reactive protein in patients with congestive heart failure

D. Tousoulis,  A. Drolias,  C. Antoniades,  C. Tentolouris,  G. Siasos,  E. Stefanadi,  S. Brilli,  C. Stefanadis, 
  • Page: 144
  • First Published: 11 December 2008
Free Access

666 Plasma adiponectin and neurohormones levels under heart failure

N.V. Scrypnik,  M.A. Orynchak, 
  • Page: 144
  • First Published: 11 December 2008
Free Access

667 The homeostatic chemokines CCL19 and CCL21 are elevated in heart failure and may regulate myocardial hypertrophy

A. Yndestad,  A.V. Finsen,  C. Husberg,  E. Oie,  M. Lipp,  L. Gullestad,  G. Christensen,  P. Aukrust, 
  • Page: 144
  • First Published: 11 December 2008
Free Access

668 Prevalence and significance of microalbuminuria in a large population of patients with chronic heart failure: data from the Italian GISSI-HF trial

R. Latini,  S. Masson,  A. Frisinghelli,  S. Barlera,  A. Gualco,  A.P. Maggioni,  G. Tognoni,  L. Tavazzi,  on behalf of GISSI-HF Investigators , 
  • Page: 145
  • First Published: 11 December 2008
Free Access

670 Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in ambulant sheep

C.J. Charles,  D.L. Jardine,  M.G. Nicholls,  M.T. Rademaker,  A.M. Richards, 
  • Page: 145
  • First Published: 11 December 2008
Free Access

671 Functional evidence for the existence of ETA-ETB receptor crosstalk in the heart

C. Bras-Silva,  D. Monteiro-Sousa,  A.J. Duarte,  A.F. Leite-Moreira, 
  • Pages: 145-146
  • First Published: 11 December 2008
Free Access

672 Anabolic deficiency as determinant of functional impairment and prognosis in heart failure patients

P. Penafiel,  D.A. Pascual Figal,  B. Redondo,  P. Nicolas,  P.L. Tornel,  J. Sanchez Mas,  G. De La Morena,  M. Valdes, 
  • Page: 146
  • First Published: 11 December 2008
Free Access

673 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure

G. Gueder,  J. Bauersachs,  S. Frantz,  D. Weismann,  B. Allolio,  G. Ertl,  C.E. Angermann,  S. Stoerk,  on behalf of Kardiologie Würzburg , 
  • Page: 146
  • First Published: 11 December 2008
Free Access

674 Prognostic value of androgens in male patients with chronic heart failure

S. Stoerk,  G. Gueder,  S. Frantz,  J. Bauersachs,  D. Weismann,  B. Allolio,  G. Ertl,  C.E. Angermann,  on behalf of Kardiologie Würzburg , 
  • Pages: 146-147
  • First Published: 11 December 2008
Free Access

675 Endothelin-1 following exercise training in congestive heart failure patients

E. Rivlin,  G.H. Zaid,  I. Maor,  U. Rosenschein,  E. Goldhammer, 
  • Page: 147
  • First Published: 11 December 2008
Free Access

676 Additive prognostic value of fT3 and BNP in heart failure patients

M. Emdin,  A. Giannoni,  R. Poletti,  A. Gabutti,  C. Mammini,  C. Prontera,  C. Passino, 
  • Page: 147
  • First Published: 11 December 2008
Free Access

677 Does andropause exist in men with chronic heart failure, and is it linked to multiple anabolic deficiency ?

E.A. Jankowska,  M. Lopuszanska,  A. Szklarska,  A. Grzeslo,  J. Majda,  M. Medras,  W. Banasiak,  P. Ponikowski, 
  • Pages: 147-148
  • First Published: 11 December 2008
Free Access

679 Reduction in serum testosterone deteriorates exercise capacity in men in the course of chronic heart failure

E.A. Jankowska,  B. Biel,  B. Ponikowska,  L. Borodulin-Nadzieja,  J. Petruk-Kowalczyk,  W. Banasiak,  P.A. Poole-Wilson,  P. Ponikowski, 
  • Page: 148
  • First Published: 11 December 2008
Free Access

680 Evidence of reduced food intake and poorer nutritional intake in chronic heart failure patients

C.M. Hughes,  C. McGartland,  G. Cran,  M.J. Roberts,  D.P. Nicholls,  P.P. McKeown, 
  • Pages: 148-149
  • First Published: 11 December 2008
Free Access

681 Apoptosis versus active gene transcription in the skeletal muscle of patients with mild to moderate chronic heart failure. Relationship with exercise capacity

V. Conraads,  V. Hoymans,  T. Vermeulen,  P. Beckers,  C. Vrints,  W. Martinet, 
  • Page: 149
  • First Published: 11 December 2008
Free Access

683 Ischemic postconditioning and its effect on beta-adrenoceptor responsiveness

K.-D. Schluter,  R. Schreckenberg,  C. Morlein, 
  • Page: 149
  • First Published: 11 December 2008
Free Access

684 Circulation adiponectin level a prognostic marker for patients with heart failure

E. Moldoveanu,  D.S. Marta,  G. Manea,  R.G. Tanaseanu,  C. Tanaseanu, 
  • Page: 149
  • First Published: 11 December 2008
Free Access

685 Evidence for improved ischemia tolerance in cardiomyocytes from failing rat hearts

M. Nouri Sharikabad,  J. Pedersen,  M. Aronsen,  H.K. Mork,  O.M. Sejersted,  I. Sjaastad,  O. Brors, 
  • Page: 150
  • First Published: 11 December 2008
Free Access

686 Effect of chronic insulin therapy in the mitochondrial function in an ex-vivo animal model of diabetes and hypercaloric diet submitted to global myocardial ischaemia-reperfusion

P.F. Monteiro,  M. Paiva,  R. Carreira,  L.M. Goncalves,  L.A. Providencia, 
  • Page: 150
  • First Published: 11 December 2008
Free Access

688 The effect of granulocyte-colony stimulating factor on left ventricular remodeling and in-stent restenosis in porcine myocardial infarction model

S.Y. Yim,  M.H. Jeong,  Y.K. Ahn,  J.H. Kim,  J.Y. Moon,  J.G. Cho,  J.C. Park,  J.C. Kang, 
  • Pages: 150-151
  • First Published: 11 December 2008
Free Access

690 Inhibitor of angiotensin II type 1 receptors Eprosartan and Amiodarone as a combined treatment of advanced heart failure and atrial fibrillation

S. Grigoryan,  A.A. Stepanyan,  L.G. Hazarapetyan, 
  • Page: 151
  • First Published: 11 December 2008
Free Access

691 Increased succes rates of cardioversion of atrial fibrillation in patients with ischemic cardiomyopathy compared with non-ischemic cardiomyopathy

L.-H. Boldt,  M. Huemer,  A.S. Parwani,  S. Rolf,  W. Haverkamp, 
  • Page: 151
  • First Published: 11 December 2008
Free Access

692 Assessment of left atria in patients with chronic heart failure developing atrial fibrillation

E.B. Luneva,  N.P. Nikitin,  A.L. Clark,  J.G.F. Cleland, 
  • Pages: 151-152
  • First Published: 11 December 2008
Free Access

693 Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension. A prospective study

H. Badran,  M.A. Eid,  A. Micheal, 
  • Page: 152
  • First Published: 11 December 2008
Free Access

694 Cytotoxin-associated gene-A bearing strains of Helicobacter pylori and atrial fibrillation due to ischaemic origin. Is there a link?

H. Badran,  M.E. Mahfouz, 
  • Page: 152
  • First Published: 11 December 2008
Free Access

695 Atrial fibrillation and heart failure: effect on exercise tolerance

M.F. Piepoli,  G.Q. Villani,  D. Aschieri,  A. Capucci, 
  • Pages: 152-153
  • First Published: 11 December 2008
Free Access

696 Persistent atrial fibrillation recurrence in the first year after cardioversion of recent onset atrial fibrillation is related with increased late high sensitivity C-reactive protein levels

A.G. Rigopoulos,  A.S. Kalogeropoulos,  S. Tsiodras,  S. Papathanasiou,  S. Dragomanovits,  E. Sakadakis,  I. Rizos,  D.T. Kremastinos, 
  • Page: 153
  • First Published: 11 December 2008
Free Access

697 Atrial fibrillation and hospitalisation rate in patients with idiopathic dilated cardiomyopathy

A. Di Lenarda,  A. Aleksova,  M. Merlo,  E. Daleffe,  I. Tavcar,  A. Pascotto,  F. Lo Giudice,  G. Sinagra,  on behalf of Trieste Heart Muscle Disease Registry , 
  • Page: 153
  • First Published: 11 December 2008
Free Access

698 Atrial fibrillation (AF) in heart failure patients after cardiac surgery: effect of two beta-blockers

G. Marazzi,  M. Volterrani,  G. Caminiti,  R. Massaro,  B. Sposato,  A. Arisi,  M. Miceli,  G. Rosano, 
  • Pages: 153-154
  • First Published: 11 December 2008
Free Access

699 Late increase of inflammatory markers in patients with recent onset atrial fibrillation is related with cardioversion outcome

A.S. Kalogeropoulos,  A.G. Rigopoulos,  S. Papathanasiou,  S. Tsiodras,  S. Dragomanovits,  E. Sakadakis,  I. Rizos,  D.T. Kremastinos, 
  • Page: 154
  • First Published: 11 December 2008
Free Access

701 Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model

C.J. Charles,  D.L. Jardine,  A.M. Richards, 
  • Page: 154
  • First Published: 11 December 2008
Free Access

703 Chronic heart failure etiology does not affect Interleukin-10 level

A.AM. Farrag,  N. El Ghandour,  M. Halim, 
  • Pages: 154-155
  • First Published: 11 December 2008
Free Access

704 Decreased small arterial compliance with increased circulating VEGF-A in dilated cardiomyopathy

Z.Y.L. Zhou,  L.X.L. Li, 
  • Page: 155
  • First Published: 11 December 2008
Free Access

705 Main determinants of left atrial volume in patients suffering from hypertrophic and dilated cardiomyopathy

R. Faludi,  L. Toth,  E. Fodi,  T. Simor,  L. Papp, 
  • Page: 155
  • First Published: 11 December 2008
Free Access

706 B-type natriuretic peptide (BNP) and ventricular arrhythmias in Chagas disease

J. Marques,  A. Kansky,  I. Mendoza,  L. Lopez-Gomez,  F. Moleiro,  F. Colmenter,  I. Mendoza-Britto,  J. Abate, 
  • Pages: 155-156
  • First Published: 11 December 2008
Free Access

707 Prevalence and etiology of restrictive filling in the hypertrophic heart

R. Kuperstein,  Y. Potashnik,  M.S. Feinberg,  D. Freimark,  M. Arad, 
  • Page: 156
  • First Published: 11 December 2008
Free Access

708 Dynamics of left ventricular systolic function and coronary flow velocity after vagal neurostimulation in patients with ischemic cardiomyopathy

E. Pavlyukova,  S. Afanasiev,  R. Karpov, 
  • Page: 156
  • First Published: 11 December 2008
Free Access

709 Apical hypertrophic cardiomyopathy can mimic ischemic heart diseases

H. Duygu,  M. Zoghi,  S. Nalbantgil,  F. Ozerkan,  A. Akilli,  M. Akin, 
  • Page: 156
  • First Published: 11 December 2008
Free Access

710 Left atrial volume: an important prognostic factor in patients with heart failure and left ventricular systolic dysfunction

A. Galrinho,  L. Moura Branco,  R. Soares,  F. Miranda,  A. Mamede,  A. Leal,  J. Abreu,  R. Cruz Ferreira, 
  • Pages: 156-157
  • First Published: 11 December 2008
Free Access

711 Carvedilol is more effective than perindopril as monotherapy in patients with chronic heart failure and alcoholic cardiomyopathy

I. Zhirov,  S. Tereschenko,  G. Sarbalinova, 
  • Page: 157
  • First Published: 11 December 2008
Free Access

712 Alterations in autonomic nervous system activity in hypertrophic cardiomyopathy: effects of body position

L. Halmai,  L. Rudas,  R. Sepp,  M. Csanady,  T. Forster, 
  • Page: 157
  • First Published: 11 December 2008
Free Access

713 Echocardiographic characteristics and relations with severity of inflammation in infection-associated transient left ventricular dysfunction

D.H. Yoon,  D.G. Park,  S.E. Kim,  J.H. Lee,  K.R. Han,  D.J. Oh, 
  • Pages: 157-158
  • First Published: 11 December 2008
Free Access

714 Isolated and preclinical impairment of left ventricular function in insulin-dependent and non-insulin-dependent diabetic patients

M.A. Khan, 
  • Page: 158
  • First Published: 11 December 2008
Free Access

715 The value of heart rate turbulence (HRT) in patients with dilated cardiomyopathy (DCM) and ventricular tachyarrhythmias (VT)

L. Lepska,  P. Zagozdzon,  M. Dudziak,  G. Raczak, 
  • Page: 158
  • First Published: 11 December 2008
Free Access

716 Prognostic role of circulatory power in patients with idiopathic dilated cardiomiopathy

A. Di Lenarda,  M. Merlo,  D. Clama,  E. Berton,  S. Pyxaras,  A. Aleksova,  A. Pivetta,  G. Sinagra,  on behalf of Trieste Heart Muscle Disease Registry , 
  • Pages: 158-159
  • First Published: 11 December 2008
Free Access

717 Cardiomyopathy associated with Emery-Dreifuss muscular dystrophy, echocardiographic and biomarker study

M. Marchel,  V. Stepien,  A. Madej,  R. Steckiewicz,  J. Kochanowski,  K.J. Filipiak,  I. Hausmanowa-Petrusewicz,  G. Opolski, 
  • Page: 159
  • First Published: 11 December 2008
Free Access

718 Dominance of T-cell-receptor Vbeta (TRBV) 7, 9, 20 and 30 in endomyocardial biopsies from patients with Parvovirus B19 associated acute myocarditis

M. Noutsias,  M. Rohde,  A. Block,  M. Hummel,  D. Lassner,  U. Kuehl,  H.P. Schultheiss,  H.D. Volk, 
  • Page: 159
  • First Published: 11 December 2008
Free Access

719 Dilated cardiomyopathy: alternative treatment with resynchronization cardiac and stem cells therapy: Preliminary results

O.T. Greco,  R.V. Ardito,  R.T. Takeda,  M.R. Lago,  J.L.B. Jacob,  E.M. Da Silva,  F.V. Salis,  A. Parro Jr, 
  • Pages: 159-160
  • First Published: 11 December 2008
Free Access

720 Dilated cardiomyopathy: labelled stem cells transplantation with 99m-Tc HMPAO to the myocardium

O.T. Greco,  J.L.B. Jacob,  F.V. Salis,  M.C. Lago,  R.V. Ardito,  M.A. Ruiz, 
  • Page: 160
  • First Published: 11 December 2008
Free Access

721 Meta-analysis on the immunohistological and histological proof of intramyocardial inflammation in myocarditis and dilated cardiomyopathy

M. Noutsias,  E. Noutsias,  H.P. Schultheiss,  U. Kuehl, 
  • Page: 160
  • First Published: 11 December 2008
Free Access

722 Comparison of sudden death circadian rhythm in chagasic versus non chagasic patients

I. Mendoza,  J.A. Marques Rodrigues,  F. Moleiro,  I. Mendoza-Britto, 
  • Pages: 160-161
  • First Published: 11 December 2008
Free Access

723 β1-Adrenergic receptor polymorphisms are correlated with exercise capacity in patients with idiopathic dilated cardiomyopathy

C. Forleo,  M. Iacoviello,  M.E. Lepera,  S. Sorrentino,  P. Guida,  G. Grandinetti,  C. Granieri,  S. Favale, 
  • Page: 161
  • First Published: 11 December 2008
Free Access

724 Correlation of the extent of left ventricular noncompaction and left ventricular function. An MRI study

L. Toth,  R. Faludi,  A. Toth,  A. Varga-Szemes,  I. Repa,  L. Papp,  T. Simor, 
  • Page: 161
  • First Published: 11 December 2008
Free Access

726 Correlation of flow mediated dilation with impaired cardiac function and circulating markers of endothelial function in patients with heart failure

A.K. Kurlianskaya,  E.S. Atroshchenko,  T.L. Denisevich,  O.V. Pashuk, 
  • Pages: 161-162
  • First Published: 11 December 2008
Free Access

727 Cytokines and oxidative stress do not regulate asymmetrical dimethylarginine (ADMA) levels in congestive heart failure

Y. Andreou,  D. Tousoulis,  C. Antoniades,  M. Karali,  C. Vasiliadou,  C. Tentolouris,  C. Tsioufis,  C. Stefanadis, 
  • Page: 162
  • First Published: 11 December 2008
Free Access

729 The comparison of noninvasive cardiac output measurement using inert gas rebreathing method with thermodilution in patients with advanced chronic heart failure qualified as heart transplant recipients

P. Sobanski,  W. Sinkiewicz, 
  • Page: 162
  • First Published: 11 December 2008
Free Access

730 Acute effects of non invasive ventilation with continuous positive airway pressure (CPAP) on pulse pressure in outpatients with chronic heart failure

M.M.P. Quintao,  S.S. Chermont,  N.N. Rocha,  E.T Tinoco Mesquita,  A.C.L. Nobrega, 
  • Pages: 162-163
  • First Published: 11 December 2008
Free Access

731 Ambulatory monitoring in heart failure patients: relationship between intrathoracic impedance and right ventricular pressures

M. Vanderheyden,  F. Braunschweig,  S. Verstreken,  D. Ersgard,  J. Janssen,  P.H.C.M. Reiters,  Y. Cho,  M. Hill, 
  • Page: 163
  • First Published: 11 December 2008
Free Access

732 Elevated filling pressures remains to be an important predictor for mortality in patients with advanced heart failure in the contemporary era

W. Mullens,  H.N. Skouri,  Z. Abrahams,  R.C. Starling,  D.O. Taylor,  W.H. Tang, 
  • Page: 163
  • First Published: 11 December 2008
Free Access

733 Prognostic role of haemodynamic evaluation at rest and during exercise in patients with idiopathic dilated cardiomyopathy

A. Di Lenarda,  S. Pyxaras,  M. Merlo,  A. Pivetta,  D. Chicco,  A. Aleksova,  B. D'agata,  G. Sinagra,  on behalf of Trieste Heart Muscle Disease Registry , 
  • Pages: 163-164
  • First Published: 11 December 2008
Free Access

734 Impaired central and peripherical haemodynamic response during muscle metaboreflex activation in heart failure patients

A. Marocco,  R. Montisci,  M. Ruscazio,  R. Solinas,  A. Crisafulli,  A. Concu,  L. Meloni, 
  • Page: 164
  • First Published: 11 December 2008
Free Access

736 Neurohormonal and haemodynamic mechanisms of the ST segment depression in heart disease and their link to heart failure

N.V. Nranyan, 
  • Page: 164
  • First Published: 11 December 2008
Free Access

737 Influence of the combined therapy with amlodipine and lisinopril on left ventricular remodelling in patients with isolated systolic hypertension

S.V. Gurgenyan,  S.K.H. Vatinyan,  K.G. Nikoghsyan,  L.B. Edilyan, 
  • Pages: 164-165
  • First Published: 11 December 2008
Free Access

738 Impact of high platelet activity on left ventricular function in patients with ST-segment elevation myocardial infarction treated with primary coronary intervention

R.P. Piatkowski,  Z. Huczek,  J. Kochanowski,  K.J. Filipiak,  P. Scislo,  G. Opolski, 
  • Page: 165
  • First Published: 11 December 2008
Free Access

739 Left atrial volume index is an independent predictor of NT pro-BNP level in patients with left ventricular dysfunction

S. Miclaus,  C. Mornos,  A. Lupu,  D. Maximov,  M. Puschita, 
  • Page: 165
  • First Published: 11 December 2008
Free Access

740 Determinants of late left ventricular dysfunction in patients with acute coronary syndrome

M.R. Babarskiene,  D. Luksiene,  B. Slapikiene,  J. Vencloviene,  I. Milvidate,  R. Slapikas, 
  • Page: 165
  • First Published: 11 December 2008
Free Access

741 Doppler derived myocardial performance index in healthy children

A. Jurko,  S. Krupickova,  A. Jurko Jr, 
  • Page: 166
  • First Published: 11 December 2008
Free Access

742 Diversity of postinfarction remodeling in patients with Q-wave myocardial infarction with successful reperfusion with streptokinase

N. Vinogradova,  L. Polonetsky,  T. Sevruc, 
  • Page: 166
  • First Published: 11 December 2008
Free Access

743 64-row Multi-Detector Computed Tomography (MDCT) as a useful tool in morphologic and functional measurements of left ventricle (LV) in patients with exercise dyspnea

M. Zagrodzka,  S. Szmit,  B. Jaron,  M. Cholewa,  G. Opolski, 
  • Page: 166
  • First Published: 11 December 2008
Free Access

744 Relationship between the wide QRS and the ventricular dyssynchrony, left ventricular filling pressure and time, RAAS and eNOS genes polymorphisms in heart failure patients

A. Kalina,  I. Palasti, 
  • Pages: 166-167
  • First Published: 11 December 2008
Free Access

745 Temporal changes between infarct size and ejection fraction following primary PCI assessed by cardiac magnetic resonance

S. Orn,  C. Manhenke,  V. Bonarjee,  T. Edvardsen,  K. Dickstein, 
  • Page: 167
  • First Published: 11 December 2008
Free Access

746 Reversibility of restrictive filling during low-dose dobutamine echocardiography predicts reverse LV remodeling after revascularization in ischemic cardiomyopathy

E. Carluccio,  P. Biagioli,  G. Vincenti,  G. Alunni,  A. Murrone,  C. Giombolini,  A. Aimi,  G. Ambrosio, 
  • Page: 167
  • First Published: 11 December 2008
Free Access

747 The extent of myocardium damage and the left ventricle thrombus in early period of acute myocardial infarction treated with successful primary PCI

M. Zielinska,  K. Kaczmarek,  W. Koniarek,  J.H. Goch, 
  • Pages: 167-168
  • First Published: 11 December 2008
Free Access

748 Prognostic significance of the evolution of the left ventricular ejection fraction in elderly patients with acute myocardial infarction

C.L. Calin,  C. Sinescu,  A. Popa,  R. Ciomag,  D. Mincu, 
  • Page: 168
  • First Published: 11 December 2008
Free Access

749 Byproducts of oxidative lipid and protein damage in patients with chronic ischemic heart failure: relationship to disease severity

S. Radovanovic,  M. Krotin,  J. Saric,  M. Zaja-Simic,  D.V. Simic,  J. Mimic-Oka,  M. Pljesa,  T. Simic, 
  • Page: 168
  • First Published: 11 December 2008
Free Access

750 Influence of regeneration of heart muscle by intracoronary autologous bone marrow cell transplantation in patients with chronic ischemic heart disease on the mobilization of CD34+ and CD133+ circulating progenitor cells

R.G. Turan,  M. Brehm,  M. Koestering,  T. Bartsch,  T. Zeus,  S. Steiner,  C.M. Schannwell,  B.E. Strauer, 
  • Pages: 168-169
  • First Published: 11 December 2008
Free Access

751 Role of non steroidal anti-inflammatory drugs in the instability of clinical picture of patients with heart failure and rheumatic diseases

E.R. Cosentino,  E.R. Rinaldi,  D. Degli Esposti,  S. Bacchelli,  A. Dormi,  M. Rosticci,  D. De Sanctis,  C. Borghi, 
  • Page: 169
  • First Published: 11 December 2008
Free Access

752 Impact of regional function on global remodeling in presence of preserved left ventricular ejection fraction

I.P. Clements, 
  • Page: 169
  • First Published: 11 December 2008
Free Access

754 Device-based CRT optimization by peak endocardial acceleration in cardiac resynchronisation therapy

H. Naegele,  P.P. Delnoy,  P. Ritter,  L. Padeletti,  S. Orazi,  F. Anselme,  F. Renesto,  V. Magagnin, 
  • Page: 170
  • First Published: 11 December 2008
Free Access

755 Combined ultrasound and ECG selection criteria increase the proportion of responders to cardiac resynchronization therapy

D. Pontillo,  A. Achilli,  M. Sassara,  F. Turreni,  P. Rossi,  P. Achilli,  E. Carluccio,  G. Ambrosio, 
  • Page: 170
  • First Published: 11 December 2008
Free Access

756 Cardiac resynchronization therapy in patients with a narrow QRS and evidence of LV dyssynchrony

M. Taborsky,  P. Neuzil,  M. Schejbalova, 
  • Page: 170
  • First Published: 11 December 2008
Free Access

757 Ambulatory blood pressure monitoring and 2D-echo in predicting non arrhythmic cardiac events after ICD implantation for MADIT II criteria. A new prognostic index

L. Antonini,  V. Pasceri,  S. Greco,  F. Colivicchi,  A. Varveri,  A. Meo,  A. Kol,  M. Santini, 
  • Page: 171
  • First Published: 11 December 2008
Free Access

758 Reverse remodeling after cardiac resynchronization therapy affects the burden of ventricular arrhythmias: the InSync ICD Italian Registry

L. Padeletti,  M. Landolina,  M. Gasparini,  M. Lunati,  M. Santini,  S. Bianchi,  G.B. Perego,  S. Valsecchi,  on behalf of InSync ICD Italian Registry , 
  • Page: 171
  • First Published: 11 December 2008
Free Access

759 Long-term effects of CRT in patients with narrow QRS: the InSync/InSync ICD Italian Registry

F. Oliva,  M. Gasparini,  M. Santini,  A. Achilli,  M. Landolina,  M. Padeletti,  G.B. Perego,  S. Bisetti,  on behalf of the InSync/InSync ICD Italian registry investigators , 
  • Page: 171
  • First Published: 11 December 2008
Free Access

760 The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure

A.L. Clark, 
  • Page: 172
  • First Published: 11 December 2008
Free Access

761 Left ventricular lead position influences optimal AV/PV delays determined by aortic VTI: preliminary results of the RESPONSE HF Trial

R. Weiss,  M. El-Zaru,  R. Malik,  A. Alawwa,  M. Wish,  K. Hsu,  E. Nobrega,  Z. Syed,  on behalf of RESPONSE HF Investigators , 
  • Page: 172
  • First Published: 11 December 2008
Free Access

762 Continuous algorithm to assess heart rate variability in heart failure patients with cardiac resynchronisation therapy

E. Marijon,  S. Boveda,  A. Bulava,  P. Defaye,  J.P. Cebron,  N. Delarche,  M. Lambiez,  P. Chevalier, 
  • Pages: 172-173
  • First Published: 11 December 2008
Free Access

763 The use of independently programmable configurations to optimize sensing and pacing and to decrease re-operation rates in CRT patients

J. Champagne,  L.D. Sterns,  B. Thibault,  J.S. Healey,  R. Yee,  C. Simpson,  E. Crystal,  M.B. Greene,  on behalf of The ELECTION Study Investigators , 
  • Page: 173
  • First Published: 11 December 2008
Free Access

764 Usefulness of an automatic patient alarm based on changes in intrathoracic impedance in patients with advanced heart failure

G. Vergara,  G. Lonardi,  M. Landolina,  G. Zanotto,  G.B. Perego,  M. Lunati,  G. Speca,  A. Varbaro, 
  • Pages: 173-174
  • First Published: 11 December 2008
Free Access

765 Is dyssynchrony alone sufficient to identify responders to cardiac resynchronisation therapy

C. Parsai,  B. Bijnens,  G.R. Sutherland,  A. Baltabaeva,  P. Claus,  G. Derumeaux,  M. Cannesson,  L. Anderson, 
  • Page: 174
  • First Published: 11 December 2008
Free Access

766 Incidence of atrial and ventricular arrhythmias in heart failure patients treated by cardiac resynchronization therapy: a prospective, observational study

S. Boveda,  E. Marijon,  A. Bulava,  J.P. Cebron,  P. Defaye,  N. Delarche,  M. Lambiez,  P. Chevalier,  on behalf of MONA LISA , 
  • Page: 174
  • First Published: 11 December 2008
Free Access

767 Prognostic role of ventricular dyssynchrony in patients with chronic heart failure

O.Y. Khaleva,  N.P. Nikitin,  A.L. Clark,  K. Good,  A. Rigby,  J.G.F. Cleland, 
  • Pages: 174-175
  • First Published: 11 December 2008
Free Access

768 Comparison of the prognosis of heart failure patients with wide QRS receiving cardiac resynchronisation therapy, and patients with narrow QRS

B. Szabo,  M. Dekany,  N. Nyolczas,  E. Marosi,  T. Borsanyi,  J. Bencze,  I. Preda,  R.G. Kiss, 
  • Page: 175
  • First Published: 11 December 2008
Free Access

769 Effect of cardiac resynchronization therapy on left ventricular rotation and torsion: an echocardiographic assessment with the novel technique speckle tracking

M.S. Yilmazer,  A. Aydin,  A. Akyol,  B. Dagdeviren, 
  • Page: 175
  • First Published: 11 December 2008
Free Access

770 Evaluation of cardiogenic impedance signals at different body postures in dogs and pigs

N. Holmstrom,  A. Blomqvist,  M. Ohlander,  J. Svahn,  J. Wiener,  S.-E. Hedberg,  E. Park,  S. Bowald, 
  • Pages: 175-176
  • First Published: 11 December 2008
Free Access

772 Ventricular wall stress in heart failure

P. Alter,  H. Rupp,  B. Maisch, 
  • Page: 176
  • First Published: 11 December 2008
Free Access

773 Increased chemosensitivity to hypoxia and hypercapnia is associated with right ventricular function in heart failure patients

A. Giannoni,  A. Gabutti,  M. Micalizzi,  F. Bramanti,  C. Mammini,  F. Micheletti,  M. Emdin,  C. Passino, 
  • Page: 176
  • First Published: 11 December 2008
Free Access

774 Levosimendan improves mechanical efficiency in stunned pig hearts

S. Muller,  O. Jakobsen,  O.-J. How,  T. Myrmel, 
  • Page: 176
  • First Published: 11 December 2008
Free Access

775 Electrical conduction parameters in normal and dilated hearts

D. Vaccari,  R. Mantovan,  V. Calzolari,  G. Masaro,  G. Valente,  P. Silvestri,  A. Mantesso,  G.F. Neri, 
  • Page: 177
  • First Published: 11 December 2008
Free Access

776 Vasopressin relates inversely to haemoglobin in decompensated chronic heart failure

J. Silva Marques,  C. Goncalves,  H. Luz Rodrigues, 
  • Page: 177
  • First Published: 11 December 2008
Free Access

777 Increase in lipid peroxidation and oxidative protein damage in chronic heart failure: relation between oxidant stress and ventricular remodeling

S. Radovanovic,  M. Krotin,  D.V. Simic,  N. Ninkovic,  S. Djordjevic,  J. Mimic-Oka,  T. Simic, 
  • Pages: 177-178
  • First Published: 11 December 2008
Free Access

778 Plasma surfactant protein-B and functional impairment in chronic heart failure

P. Penafiel,  D.A. Pascual Figal,  J. Sanchez Mas,  G. De La Morena,  B. Redondo,  I.P. Garrido,  J. Gonzalez,  M. Valdes, 
  • Page: 178
  • First Published: 11 December 2008
Free Access

780 Levosimendan improves endothelial function and reduces soluble adhesion molecule levels in patients with advanced heart failure

V. Bistola,  A. Karavidas,  J.T. Parissis,  S. Arapi,  D. Farmakis,  L. Rallidis,  G. Filippatos,  D. Kremastinos, 
  • Page: 178
  • First Published: 11 December 2008
Free Access

781 Endurance training in patients with stable chronic heart failure and healthy subjects: Effects on the expression of a muscle-specific E3-ligase in skeletal muscle biopsies

S. Gielen,  V. Adams,  M. Sandri,  S. Erbs,  A. Linke,  R. Hambrecht,  G. Schuler, 
  • Pages: 178-179
  • First Published: 11 December 2008
Free Access

783 Effect of physical and mental stress on HR and HRV before and after exercise training among patients with cardiac diseases

S. Carles,  D. Curnier,  A. Pathak,  J. Roncalli,  M. Bousquet,  J.L. Garcia,  J.M. Senard,  M. Galinier, 
  • Page: 179
  • First Published: 11 December 2008
Free Access

784 Raised central venous pressure (CVP) leads to a decreased glomerular filtration rate (GFR) in patients with congestive heart failure

D. Karia,  S. Mehta,  H. Ra,  R. Ishac,  D.L. Morris, 
  • Page: 179
  • First Published: 11 December 2008
Free Access

786 Increased prevalence of biventricular dysfunction in patients with Type 2 Diabetes Mellitus

M.R. Movahed,  N. Milne, 
  • Pages: 179-180
  • First Published: 11 December 2008
Free Access

787 High platelet activity predicts impaired left ventricular function in patients with ST-segment elevation myocardial infarction

R.P. Piatkowski,  Z. Huczek,  J. Kochanowski,  J. Kochman,  K.J. Filipiak,  P. Scislo,  G. Opolski, 
  • Page: 180
  • First Published: 11 December 2008
Free Access

788 Risk factors for rehospitalization in the elderly with chronic heart failure with preserved and impaired systolic function

S. Bozinovic,  A. Grdinic,  D. Stamenkovic,  M. Stojadinovic,  I. Markovic,  M. Bojic, 
  • Page: 180
  • First Published: 11 December 2008
Free Access

789 Treadmill test is a useful tool for rate control strategy in permanent atrial fibrillation

D.A. Kosior,  J. Kochanowski,  P. Scislo,  M. Marchel,  M. Roik,  G. Opolski, 
  • Page: 180
  • First Published: 11 December 2008
Free Access

790 Echocardiography standard and tissue Doppler imaging: guide to electrical treatment of severe heart failure

C. Torromeo,  P. Pellicori,  F. Sbandi,  A. Calicchia,  A. Papa,  C. Vittori,  F. Barillà,  G. Critelli, 
  • Page: 181
  • First Published: 11 December 2008
Free Access

791 The role of left ventricle isovolumic contraction and ejection phase parameters at rest and during stress echocardiography in predicting exercise tolerance in ischemic heart failure patients

P. Rubis,  P. Podolec,  L. Tomkiewicz-Pajak,  G. Kopec,  W. Tracz, 
  • Page: 181
  • First Published: 11 December 2008
Free Access

793 Do ventricular arrhythmias influence mortality in post myocardial infarction patients with heart failure?

R. Sankaranarayanan,  M.A. James,  S. Burtchaell,  R. Holloway, 
  • Pages: 181-182
  • First Published: 11 December 2008
Free Access

794 QRS width is a predictive factor for sudden death or appropiate ICD therapy in patients with left ventricle systolic dysfunction

R. Prieto,  J.A. Serrano,  D. Pascual,  R. Munoz,  J.A. Garcia Robles, 
  • Page: 182
  • First Published: 11 December 2008
Free Access

848 Body mass index is associated with parameters of diastolic dysfunction

M.R. Movahed,  Y. Saito, 
  • Page: 183
  • First Published: 11 December 2008
Free Access

849 Strict glycemic control is associated with improvement of microcirculation and increase of exercise capacity in heart failure patients with type 2 diabetes

D. Filatov,  V.Y. Mareev,  O.Y. Narusov,  Y.V. Lapina,  Y.N. Belenkov, 
  • Page: 183
  • First Published: 11 December 2008
Free Access

850 Hemodynamic profiles and renal impairment in patients with cardiac dysfunction

K. Damman,  G. Navis,  T.D.J. Smilde,  A.A. Voors,  W. Van Der Bij,  D.J. Van Veldhuisen,  H.L. Hillege, 
  • Page: 184
  • First Published: 11 December 2008
Free Access

851 Role of segmental and whole body bioelectrical impedance analysis (BIA) in acute heart failure diagnosis

G. Parrinello,  S. Paterna,  D. Torres,  A. Fatta,  P. Di Pasquale,  G. Licata, 
  • Page: 184
  • First Published: 11 December 2008
Free Access

852 How does anaemia affect central haemodynamics in patients with heart failure ?

D. Karia,  H. Ra,  R. Ishac,  S. Mehta,  D. Morris, 
  • Pages: 184-185
  • First Published: 11 December 2008
Free Access

853 Congestive heart failure and osteoporosis in the elderly patient

S. Abou-Raya,  A. Abou-Raya, 
  • Page: 185
  • First Published: 11 December 2008
Free Access

854 Prognostic importance of anaemia and renal insufficiency in patients with left ventricular systolic dysfunction following acute myocardial infarction

S. Nabais-Araujo,  S. Rocha,  P. Azevedo,  J. Costa,  J. Marques,  M. Torres,  M. Alvares-Pereira,  A. Correia, 
  • Page: 185
  • First Published: 11 December 2008
Free Access

855 Effect of an integrated approach to care on heart failure patients with hypertension

E.R. Cosentino,  E.R. Rinaldi,  D. Degli Esposti,  S. Bacchelli,  D. De Sanctis,  F. Santi,  A. Dormi,  C. Borghi, 
  • Pages: 185-186
  • First Published: 11 December 2008
Free Access

856 The impact of heart failure on the characteristics and management of atrial fibrillation patients

L. Eurlings,  R. Nieuwlaat,  Y.M. Pinto,  H.J. Crijns,  on behalf of The Euro Heart Survey investigators , 
  • Page: 186
  • First Published: 11 December 2008
Free Access

857 Serum hepcidin is not linked to iron status in patients with chronic heart failure

A. Grzeslo,  E.A. Jankowska,  T. Witkowski,  J. Majda,  J. Petruk-Kowalczyk,  W. Banasiak,  P. Ponikowski, 
  • Page: 186
  • First Published: 11 December 2008

Author Index

Free Access

Author Index

  • Pages: 187-200
  • First Published: 11 December 2008

Index of Topics

Free Access

Index of Topics

  • Pages: 201-202
  • First Published: 11 December 2008

Abstracts

Free Access

9 A review of the actual need and evolution of need for device therapy in a community heart failure population

H.M. Sulaiman,  C. O'Loughlin,  C. Conlon,  D. McCaffrey,  M. Ledwidge,  K. Mcdonald, 
  • Pages: 227-228
  • First Published: 11 December 2008